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RESUMO 
 
 
Partículas magnéticas constituem plataformas com propriedades únicas para a purificação 
de proteínas e ensaios antimicrobianos. 
 
Neste trabalho partículas magnéticas foram funcionalizadas com novos ligandos que foram 
utilizados para a purificação de proteínas. Devido às suas características inovadoras, estes 
ligandos foram estudados por técnicas de modelação e simulação molecular, de modo a 
explicar a interação entre dois pares de afinidade: GFP/LA-A4C7 e RK-GFP/LR-A7C1. Os 
resultados obtidos apontam para uma interação entre GFP e LA-A4C7 de natureza hidrofóbica, 
enquanto a interação entre RK-GFP e LR-A7C1 é assegurada por pontes de hidrogénio. Uma 
segunda biblioteca de ligandos de afinidade para a purificação da GFP foi idealizada com base 
na maximização da energia livre de ligação estimada e correspondente constante de afinidade. 
 
Ao imobilizar os ligandos biomiméticos nas partículas magnéticas foi possível eluir a 
proteína de interesse e recuperá-la com elevada pureza. As condições ideais de eluição para 
GFP foram 0.1mM glicina-NaOH pH9 50% (v/v) etileno glicol e as melhores condições de 
eluição para RK-GFP foram PBS pH7.4, 500mM arginina. As constantes de ligação para os 
sistemas estudados (Ka=0.83×105M-1 e Qmax=4mg/g para GFP/LA-A4C7, Ka=3.21×10
5M-1 e 
Qmax=2mg/g para RK-GFP/LR-A7C1) são promissoras para um sistema de purificação de 
proteínas por afinidade. Os resultados experimentais estão de acordo com os resultados 
teóricos. 
 
Finalmente, MNPs foram funcionalizadas com o (RW)3, um péptido com propriedades 
antimicrobianas, por diferentes métodos de imobilização. Foi possível observar o potencial 
antimicrobiano contra Escherichia coli e Bacillus subtilis de um novo dispositivo baseado no 
método de imobilização por “EDC-coupling”. 
 
Palavras-chave: nanopartículas magnéticas; ligandos de afinidade; modelação e simulação 
molecular; purificação de proteínas; péptidos antimicrobianos  
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ABSTRACT  
 
 
Magnetic nano- and microparticles are unique platforms for the development of 
bioseparation and antimicrobial devices.  
 
This work explored the application of magnetic particles for the purification of fusion 
proteins through the use of magnetic adsorbents coupled to novel affinity ligands towards 
peptidic and proteic tags. Furthermore, and in view of the novelty of these ligands, molecular 
modeling and simulation techniques were employed to explain the key structural features 
involved in the binding of two affinity pairs: GFP/LA-A4C7 and RK-GFP/LR-A7C1. The results 
showed that the interaction between GFP and LA-A4C7 is mainly hydrophobic while the 
interaction between RK-GFP and LR-A7C1 is mostly driven by hydrogen bonds. Moreover, the 
same modeling techniques have been used to idealize a theoretical second generation library 
with view of maximizing the estimated free energy of binding and the correspondent affinity 
constant.  
 
When immobilizing the biomimetic ligands LA-A4C7 and LR-A7C1 onto magnetic 
nanoparticles, it was possible to bind the protein of interest and recover pure elution fractions. 
The best elution condition for GFP elution was 0.1mM glycine-NaOH pH9 50% (v/v) ethylene 
glycol and the best elution condition for RK-GFP elution was PBS pH 7.4, 500mM arginine, 
which are in accordance with the theoretical results described previously. Final binding 
constants for the studied systems (Ka=0.83×105M-1 and Qmax=4mg/g for GFP/LA-A4C7, 
Ka=3.21×105M-1 and Qmax=2mg/g for RK-GFP/LR-A7C1) show promising results for an affinity-
based protein purification system.  
 
Magnetic particles were also functionalized with (RW)3, an peptide with antimicrobial 
properties, by different routes. We were able to develop a novel antimicrobial nanodevice 
based on the EDC-coupling of (RW)3 that has shown antimicrobial activity against Escherichia 
coli and Bacillus subtilis. 
 
Keywords: magnetic nanoparticles; affinity ligands; molecular modeling and simulation; 
protein purification; antimicrobial peptides  
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1.1. Magnetic core materials 
1.1.1. Synthesis, coating and functionalization 
Magnetic nanonoparticles (MNPs) are usually formed by maghemite (Fe2O3) or magnetite 
(Fe3O4), usually in the nano- to micrometer range. Usually MNP have single domains of about 
5-20nm in diameter [1]. MNP exhibit superparamagnetic behavior and become easily 
magnetized upon exposure to a magnetic field [2]. 
 
Many synthesis techniques have been applied to obtain high quality iron oxide dispersed 
MNP, as co-precipitation, thermal decomposition, microemulsion, hydrothermal, 
electrochemical or biological synthesis. These methods have been reviewed and compared 
elsewhere (e.g. [3–5]).  
The most commonly used method is the co-precipitation, an efficient and easy method to 
synthesize high amounts of magnetite MNPs [3]. This reaction occurs at a defined 
stoichiometric Fe2+/Fe3+ ratio by the addition of a strong base under inert atmosphere [5]. The 
overall reaction may be written as: 
 
                                                                  
 
The main disadvantage of this method is that it allows a low control of shape, size 
distribution and leads to particle aggregation [5]. However these parameters can be tuned by 
changing the type of salts used, the Fe2+/Fe3+ ratio, temperature, pH and ionic strength of the 
media [6]. 
 
Due to their small size and large surface area, non-coated MNPs tend to aggregate [5,7]. 
Steric or electrostatic stabilization through coating is required to ensure stable aqueous 
dispersions [4], as well as increased biocompatibility, decreased non-specific interactions and 
facilitated functionalization [8]. The presence of hydroxyl groups at the MNPs surface allows a 
versatile functionalization [4]. 
Biopolymers are widely used for MNP stabilization [4], as they are renewable, generally 
non-toxic and biodegradable. Dextran is a R-D-glucopyranosyl polyssaccharide [3] and it is the 
mostly used polymer for MNP coating [2]. It confers optimal polar interactions with iron oxide 
surfaces, stability in physiological fluids [4], biocompatibility [5] and provides a chemical 
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handle for further chemical modification with proteins [9] and affinity ligands for purification 
purposes [10]. 
Synthetic polymers are also employed for MNP coating (e.g. poly(ehtyleneglycol) (PEG), 
poly(vinyl alcohol), poly(lactide acid), alginate, polyacrylic acid), with different advantages. For 
example, PEG-coated MNP are hydrophilic, water-soluble and biocompatible; inorganic coating 
can decrease MNP oxidation, and silica is the most commonly used by providing stability, 
biocompatibility and hydrophilicity [5]. 
 
MNPs have been used in a wide range of applications, as sealants, damping agents, drug 
and gene delivery vehicles, MRI contrast agents and materials for tissue engineering. These 
applications have been thoroughly described elsewhere [3–5]. In this work the potential of 
MNPs for bioseparation and as antimicrobial devices has been explored. 
 
1.1.2. MNP as solid-support for affinity-based bioseparation 
Recombinant proteins are used in numerous areas of biosciences and biotechnology [11]. In 
2010 the market for recombinant proteins exceeded USD100 billion and it is expected to rise 
up to USD169 billion by 2014 [12]. However, protein purification accounts as much as 60-90% 
of the total production costs [7]. This step is usually performed using a combination of 
chromatography, ultrafiltration, precipitation, among others techniques [11].  
 
Currently affinity-based separations are the most powerful tools available for downstream 
processing [11]. These include affinity chromatography [13], which is based on a specific, 
reversible and non-covalent interaction between a pair of complementar molecules (e.g. a 
ligand and a tag) [14]. Due to this high specificity, the use of affinity methods reduces non-
specific interactions, increases yields and facilitates the elimination of contaminants [14]. 
 
To confer selectively to the solid-support, the separation matrix must be functionalized 
with specific affinity ligands. Currently there are three main categories of affinity ligands: 
biological, structural and synthetic ligands. 
 
Biological ligands are biological molecules that recognize their specific and natural binding 
targets. These ligands present high selectivity and are well-established and optimized. 
However they present some disadvantages, as the high purification cost, instability with 
consequent leaching and product contamination, and high cost for large-scale production 
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[15,16]. The most well-known example is Protein A that binds selectively to the Fc domain of 
antibodies [13]. 
 
Structural ligands are based on easy chemistry, which can produce at affordable prices and 
are stable to harsh conditions as sterilization and cleaning-in place procedures [17]. The most 
used strategy is the immobilized metal ion affinity chromatography (IMAC), that is based on 
interaction between a metal ion (Co2+, Ni2+, Cu2+, Zn+2) immobilized on a matrix and specific 
aminoacid side chains [17].  However these ligands are not suitable for metal-containing 
protein purification, and are prone to metal leakage and unspecific binding [17]. 
 
Synthetic ligands are tailor-made molecules that mimic natural biological interactions [14]. 
These are derived from a combination of modeling studies, in silico approaches and high 
throughput combinatorial chemistry techniques [15]. These methods allow the discovery of 
robust alternatives for known biological ligands [16]. Synthetic ligands allow to overcome the 
disadvantages of biological ligands, while maintaining affinity and specificity and improving 
their characteristics [14]. Triazine-based ligand 22/8 [18] and ligand 8/7 [19] and Ugi-based 
ligands [15] have shown to display affinity towards human IgG. 
 
Instead of developing individualized purification protocols for each protein, the purification 
of recombinant proteins can be simplified by genetically fusing the protein to an affinity tag 
[17]. Tags are defined as exogenous, preferentially short amino acid sequences that present a 
high affinity for a specific ligand. Tags should allow the purification of tagged-proteins with 
high yields and purity, have minimal effect on the tertiary structure and biological activity of 
the protein, be non-immunogenic and non-toxic [13,17,20]. Depending on the final 
application, tags do not need to be removed after protein purification [13]. 
 
On the other hand, many authors have explored the use of non-chromatographic tags. 
These methods allow protein purification due to the properties conferred by the tags, reducing 
the cost of using affinity resins [13]. These include elastin-like polypeptide or annexin-B 
tagged-proteins that allow the selective and reversible precipitation of the fusion protein in 
response to temperature and ionic strength changes [13]; phasin-tagged proteins are co-
expressed with polyhydroxybutyrate or polyhydroxyalkanoates granules, binding selectively to 
the granules which are recovered by centrifugation [13,17]; other tags promote the formation 
of inclusion bodies to facilitate the purification steps  [21]. 
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Tags can be used due to other properties besides protein purification. 
Self-cleaving tags (e.g. inteins) can be used to avoid external tag-cleavage methods. These 
tags have inducible proteolytic activity [13,21], which can be triggered by changes of solution 
pH or the addition of a thiol reagent [17,21]. 
Other properties can be conferred by a tag such as improved protein yield, proteolysis 
prevention, protection of the host against antigenicity of the fusion protein, facilitated protein 
refolding and increased solubility [17,21]. 
 
A typical affinity separation method based on affinity tags is simple, starting with the 
expression of a target protein fused with a tag. Afterwards the protein crude extract is 
incubated with the matrix containing the immobilized ligand, cell contaminants are washed off 
and the target protein is eluted from the matrix by a sudden change in conditions (e.g. pH, 
ionic strength, use of solutions with chaotropic salts or with polarity reducing agents) [11,13]. 
However the traditional affinity chromatography presents several technical disadvantages, 
as fouling when using viscous samples and limitations by pore diffusion. To overcome these 
disadvantages, other affinity techniques with novel solid supports have been investigated. A 
well-studied example are magnetic core materials functionalized in order to selectively capture 
the desired molecule. 
 
MNPs have several advantages when compared to standard bioseparations procedures. 
The target compounds can be isolated directly from crude samples (e.g. blood, cultivation 
media) [1,22]. Their magnetic properties also allow to easily and selectively remove the 
functionalized MNPs from viscous sample solutions [1]. MNPs can be used in batch processes 
which allows to work with various sample volumes [1]. MNPs have a highly accessible surface 
area and are non-porous supports, therefore bioseparations are not limited by pore diffusion 
[7,22]. 
MNPs have been explored as a solid support for magnetic separation of various 
biomolecules [7].  
To be suitable for protein purification, MNPs should (1) be stable under synthesis, screening 
and  elution conditions, (2) hydrophilic and inert, (3) amenable to further  functionalization 
[22], (4) responsive to an external magnetic field, (5) possess large surface areas, (7) 
reasonable price, and (9) easy production methods [8].  
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Similar to chromatographic affinity separations, various biological molecules have been 
used to functionalize the coated-surface of MNPs [1,8] (Table 1.1). These can be based on 
general non-specific (electrostatic, hydrogen bonding, hydrophobic), or group-specific 
interactions (chelating, IMAC [23], and specific affinity interactions (antibody-antigen pair [24], 
steptavidin-biotin [25], avidin-biotin, enzyme-inihibitor, other ligands [26,27]). 
 
Table 1.1 - Examples of affinity ligands used to functionalize magnetic carriers for protein purification purposes.  
Purified protein Affinity ligand  Reference 
Luciferase (His-tagged) Ni
2+ 
[23] 
Haemoglobin Cu
2+
 [28] 
Biotinylated peptides Streptavidin [29] 
Nisin Z Anti-nisin antibody [30] 
Trypsin Soybean trypsin inhibitor [31] 
Human serum albumin Cibacron Blue F3GA [27] 
Lysozyme Cibacron Blue F3GA [26] 
IgG Ligand 22/8 [10] 
IgG Ligand 8/7 [22] 
 
1.1.3. MNP as solid-support for antimicrobial peptides tethering 
The use of antibiotics has led to the appearance of multi-drug resistant microorganisms, 
specially in hospital environments. AntiMicrobial Peptides (AMPs) are seen as promising 
alternatives [32], capable of eliminating a broad spectrum of microorganisms, including Gram-
positive [33] and Gram-negative [34] bacteria and fungi [32]. AMPs are a promising class of 
molecules which have shown to be able to reduce infections without easily incurring pathogen 
resistance [33,35], or cross-resistance [32]. 
Most known AMPs share the same characteristics: (a) positively charged residues, and (b) 
residues with a hydrophobic side chain [36]. High contents of phosphatidyl serine and 
phosphatidyl glycerol (negatively charged at physiological pH) at the outer layer of most 
bacterial membranes allow the preferential activity of AMPs [32,37]. Upon contact with the 
bacterial membrane, AMPs adopt a particular secondary conformation, allowing the insertion 
of the hydrophobic components into the membrane lipid domains and the disruption of its 
structure [37]. Two mechanisms for AMP action have been proposed - pore-forming and non-
pore forming – and have been reviewed thoroughly elsewhere [37]). Both rely on the physical 
disruption of the bacterial membrane structure [37]. 
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Nowadays the choice of antimicrobial molecules is large and tends to increase.  Hybrid 
antimicrobial materials have two or more functional fragments combined [35] – some 
literature examples are described in Table 1.2.  
 
Table 1.2 - Examples of AMP-functionalized solid supports. 
Solid support AMP Microbes tested Antimicrobial assay Reference 
Supermagnetic iron 
oxide particles 
Bacitracin 
E. coli, S. aureus, B. 
subtilis 
Agar plating; OD 
measurement 
[38] 
Silica magnetic 
microparticles 
Magainin I Listeria ivanovii 
Fluorescencent LIVE/DEAD 
Baclight assay 
[33] 
Nickel magnetic 
nanoparticles 
LL-37 E.coli Disk diffusion test [34] 
Silver nanoparticles G3R6TAT 
B. subtilis, E. coli, 
Candida albicans 
Broth microdilution 
method 
[39] 
Multi-wall carbon 
nanotubes 
Nisin 
E. coli, P. aeruginosa, 
S. aureus, B. subtilis 
Agar plating [40] 
Titanium (Ti) 
surface 
Cys-Tet213 P. aeruginosa Fluorescence assay [41] 
Stainless steel 
surface 
Magainin I 
and nisin 
L. ivanovii Agar plating [42] 
Quartz surface Cys-Tet213 P. aeruginosa Fluorescence assay [43] 
Discs of various 
materials 
apoE 
derivates 
S. aureus, P. 
aeroginosa 
Neutral red and MTT assay; 
disk diffusion test 
[44] 
 
Antibacterial coatings are based on the immobilization of AMPs onto planar surfaces while 
keeping its accessibility and antimicrobial activity. Recent examples include functionalization of 
titanium [41,43,45], quartz [43] and steel surfaces [42]. Although functionalization of planar 
surfaces yields protection against biofilm formation, it is inefficient against bacteria present in 
the surrounding medium [33]. 
 
Nanostructured antimicrobials allow an increased local charge density and general 
enhanced antimicrobial activity [37]. 
Although magnetic silver nanomaterials are the most studied as antimicrobial agent [46], 
metal oxide nanoparticles functionalized with AMPs have been recently described as 
antimicrobial agents and gather great interest [38]. Magnetic iron oxide [38], silica [33] and 
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nickel [34] particles have been functionalized with various AMPs in order to display 
antimicrobial activity against Gram-positive and Gram-negative bacteria. Properly 
functionalized particles are able to disinfect a solution containing bacteria, while their 
magnetic properties allow easy removal from solution which would avoid environmental 
dissemination [33]. 
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Magnetic particles have been used in a wide range of applications, due to their versatile 
properties, as large surface area to volume ratio and superparamagnetic properties. In this 
work the potential of MNPs for bioseparation and as antimicrobial devices has been explored. 
 
New affinity pairs ligand-tag were previously developed by the Biomolecular Engineering 
Group@REQUIMTE  [47]. In this work, interesting Ugi-based lead ligands specific for the 
purification of green fluorescent protein (GFP) and GFP tagged-systems were developed. The 
ligands were obtained by a combined methodology of synthesis of libraries of ligands 
immobilized on solid support (agarose) and subsequent high-throughput screening (HTS). 
The tagged-GFP studied in this work comprised a protein tag at N-terminus composed by 
the “RKRKRK-PPP-DDDKG-TGS-“ amino acid sequence (RK-GFP). Lead ligands for GFP and RK-
GFP are shown in Table 2.1.  
 
Table 2.1 – The affinity pairs studied in this work. The chemical group used to immobilize the ligand onto the solid 
support is highlighted in red. 
Target 
protein 
GFP  RK-GFP 
Lead 
Affinity 
Ligand 
LA-A4C7 
 
LR-A7C1 
 
 
 
Previous work has also included the study of others tags with versatile properties, as 
antimicrobial properties (RWRWRW-tag) or induction of the formation of inclusion bodies 
(WFWFWF-tag) [47]. 
 
Based on these previous results, and in view of the importance of magnetic supports for 
several biotechnological and biomedical areas, this dissertation had three main goals: 
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(1) To study the potential key structural features of the interaction between the 
recombinant proteins GFP and RK-GFP with the respective lead ligand, employing 
homology modeling, automated docking and molecular dynamics simulation protocols. 
 
(2) To study the potential of the novel biomimetic ligands for recombinant protein (GFP 
and RK-GFP) purification purposes when coupled to magnetic supports. 
 
(3) To study the potential of MNPs as antimicrobial devices through the coupling of (RW)3, 
an antimicrobial peptide, against Gram-positive and Gram-negative bacteria. 
 
 
Figure 2.1 – Schematic representation of the research work followed in this work. 
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3.1. Materials 
The reagents utilized were of the highest grade available. 
 
For the MNP synthesis and surface modification we used dextran (40000g/mol; A2249.100) 
from Biochemica, poly(ethylene glycol) (10000g/mol; 81280), ammonium hydroxide 25% 
(986030501), ninhydrin (33437) from Fluka, iron(III) chloride (44944), iron(II) chloride (44939), 
phenol (185450) and  potassium cyanide (207810)  from Sigma, ethanol absolute 
(1210851212) from Panreac, (3-aminopropyl)trithoxysilane (APTES) (44014-0), pyridine 
(00633BE-137) from Aldrich and glycine (120072500) from Acros. A sample of silica/dextran- 
and silica/PEG-coated MNPs has been kindly provided by Iris Batalha from the Biomolecular 
Engineering Group (FCT-UNL). 
For ligand attachment onto MNP we used glutaric dialdehyde (340855), N,N-
dimethylformamide (33437) from Sigma, sodium hydroxide (1316871211) from Panreac, 
methanol (8388.5) from Roth, isopropyl isocyanide (553344) from Aldrich. For ligand synthesis, 
the chemical compounds were aminoisophtalic acid (33437) from Sigma, succinamic acid 
(134376), 4-aminobenzamide (284572), 3-(4-hydroxyphenyl)propionic acid (H52406), 1-
pyrenemethylamine hydrochloride (410705) and phenylacetic acid (P16621) from Aldrich. 
Further chemicals used were ethylene glycol (31000012131623), sodium-di-hydrogen 
phophate 1-hydrate (1319651211), (Di) sodium-hydrogen phosphate 2-hydrate (12507.1211) 
and sodium chloride (1316591211) from Panreac and L-arginine (W381918) from Sigma. 
 
For protein quantification using Green Fluorescent Protein rTurboGFP (FP552) from 
Evrogen and bovine serum albumin (A7906) were used as standards. The BCA kit (BCA1) from 
Sigma was employed as the colorimetric test for total protein quantification. Fluorescence 
intensity measurements (λexcitation=485nm and λemission=535nm) were used for GFP 
quantification. SDS-PAGE was performed using β-mercaptoethanol (M6250), glycerol (G9012) 
from Aldrich, Tris (MB01601) from Nzytech, 30% acrylamide and bis-acrylamide solution 19:1 
(161-0158), sodium dodecyl sulphate (SDS) (161-0416) from Biorad, ammmonia persulfate 
(APS) (9592.2), tetramethylethylenediamine (TEMED) (2867.3), Coomassie Blue R-250 from 
Roth, 2-butanol (1310891611) from Panreac. For gel staining, silver stain plus (161-0449) from 
Bio-Rad was used. 
Peptide immobilization was done with sulfosuccinimidyl-4-(N-
maleimidomethyl)cyclohexane-1-carboxylate (sulfo-SMCC) (22322) from Thermo-scientific, 
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ethylenediamine tetraacetic acid (EDTA), N-(3-dimethylaminopropyl)-N'-ethyl-carbodiimide 
(EDC) (39391) and N-Hydroxysuccinimide (NHS) (130672) from Aldrich, L-cystein (16931) from 
Roth. The peptides were synthesized by GeneCust: Cys-PP-RWRWRW (PO#P110192) and 
RWRWRW (PO#P120175_5). 
Bacterial growths were performed using Luria Broth (LB) (MB02802), ampicilin (MB0260) 
from Nzytech, agar powder (RM026) from Himedia. Escherichia coli K12 was kindly provided by 
Doutor Pedro Vidinha (FCT-UNL) and Bacillus subtilis 168 was kindly provided by Professor 
Isabel Sá Nogueira (FCT-UNL). 
Protein production was performed using NZY5α competent cells (MB00401) and BL21(DE3) 
competent cells (MB00601) from Nzytech. The DNA fragments were cloned in the pET21-c 
expression vector by GeneartTM. Protein induction was done using isopropyl β-D-1-
thiogalactopyranoside (IPTG) (MB0210) from Nzytech. DNA purification was achieved using 
NZYMiniprep (MB01001) from NZYTech. Agarose gels were done using agarose (MB02702), 
Tris Base (MB01601) from Nzytech and bromophenol blue (A512.1) from Roth. Green Safe 
(MB08801) was used for agarose gel staining and NZYDNA Ladder III (MB0440) was used as 
molecular weight marker from Nzytech. 
 
3.1.1. Equipment 
For MNP synthesis and functionalization a mechanic stirrer, a Sonicator SilverCrest and an 
Incubator KS4000ic from IKA were used. The DLS measurements were performed in a Dynamic 
Zetasizer NanoZS from Malvern (ITQB, UNL). A Water-bath SHC 2000 from Scanvac was used 
for the Kaiser test. The screening assays were performed using a Centrifuge Scanspeed from 
Scanlab. Mini-Protean Tetra System from BIO-RAD was utilized for the electrophoresis SDS-
PAGE gels. 
Temperature control during large scale production of protein and microbial pre-inoculum 
and growth were performed using the IKA Incubator described above. A Hearaeus multifuge 
X39 Centrifuge from Thermo Scientific and a Beackman Couter Optima LE-80K Ultracentrifuga 
were used for crude extract purification. DNA concentration and purity ratios were calculated 
using a Nanodrop ND-1000 spectrophotometer (courtesy of Professor Alice Pereira, FCT-UNL). 
The Microplate Reader Tecan Infinite F200 from Tecan was used to perform all the 
spectrophotometric and spectrofluorometric measurements. Colometric assays were analyzed 
using a Microplate 96-well Flat bottom Transparent Polystyrene (Starstedt) and in the 
fluorescence studies, BRAND Plates-Imunograde Tech Scientific were used. 
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Fluorescence microscopy assays were performed using an Olympus BX51 microscope (400X 
magnification), a U-MWB filter (λexc=460–490nm; λem=515–700nm) and an Olympus U-RFL-T 
lamp. 
3.2. Methods 
3.2.1. Molecular modeling methods 
1. Structure template searching 
The ExPASy translate tool (http://web.expasy.org/translate/) was used to translate the 
nucleotide sequences (5´to3’) into the protein sequences. Two query sequences have been 
used: GFP and RK-GFP. The nucleotide sequence and corresponding amino acid sequence are 
shown in Figure 3.1.  
Protein sequence identity was searched through alignment tools such as the NCBI BLASTp 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi), ExPASy SIM (http://web.expasy.org/sim/)  and EMBL-
ebi ClustalW (http://www.ebi.ac.uk/Tools/msa/clustalw2/) [48]. 
 
Figure 3.1 - Nucleotide and translated protein sequence in fasta format of the proteins (a) GFP and (b) RK-GFP.  
Identification of sequence associated homologous structures were retrieved from the RCSB 
Protein Data Bank (PDB; http://www.rcsb.org/pdb/).  
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2. Homology Modeling 
Due to the lack of a crystallographic structure available for the protein sequence used in 
this work, we employed homology modeling protocols to obtain an accurate model. Most 
software require the amino acid sequence of the protein of interest and the PDB ID code of the 
chosen template to proceed with the modeling task. Four different modeling tools were used: 
the Automated Mode of SWISS-MODEL (Swiss Institute of Bioinformatics) 
(swissmodel.expasy.org/) [49]; Modeller (Laboratory of Andrej Sali, University of California) 
module of Chimera interface [50], with resource to the MultiAlign Viewer; Rosetta software 
package (Baker’s Lab, University of Washington) [51]; I-TASSER (ZhangLab, University of 
Michigan) (zhanglab.ccmb.med.umich.edu/I-TASSER/). 
Rosetta input files comprise the Rosetta fragment database (http://robetta.bakerlab.org/), 
the structure prediction file calculated by PSIPRED v3.0 [52] 
(http://bioinf.cs.ucl.ac.uk/psipred/), and the multi pair-wise alignment by HHpred  
(http://toolkit.tuebingen.mpg.de/hhpred) [53]. In the Robetta options no homologues were 
excluded and due to lack of experimental information, no NMR information was provided (e.g. 
chemical shifts, NOE constraints, dipolar constraints). The filtering options included masking 
low complexity regions and the multiple sequence alignment options were marked as to find 
new close and distant relatives. The HHpred options were used as default. 
I-TASSER webserver was used with no additional restraints defined and no templates were 
chosen to be excluded from the I-TASSER template library. 
 
2.1. Homology models evaluation 
The inaccuracy of homology models might result from wrong packing of side chains, or 
assignment of backbone conformation in structurally undefined regions [54]. Evaluation of the 
homology modeling accuracy was monitored by the criteria described below. The homology 
models that were chosen to proceed with the modeling task were the ones that had a better 
global evaluation. 
 
 ANOLEA (Atomic NOn-Local Environment Assessment) 
(http://swissmodel.expasy.org/workspace/index.php?func=tools_structureassessment1) 
It is a packing quality score and gives information on the non-local environment energy 
for each residue. Negative values represent favorable and positive values represent 
unfavorable energy environment for a given protein residue [55]. 
 
   3. MATERIALS AND METHODS 
 
21 
 
 GROMOS 
(http://swissmodel.expasy.org/workspace/index.php?func=tools_structureassessment1) 
Evaluates each residue based on empirical force field energy and is applied to the analysis 
of obtained conformations [49]. Negative values represent favorable and positive values 
represent unfavorable energy environment for a given aminoacid [55]. 
 
 QMEAN (Qualitative Model Energy ANalysis)  
(http://swissmodel.expasy.org/qmean/cgi/index.cgi)  
Scores homology models according to the agreement of the predicted and observed 
secondary structure and solvent accessibility [56]. It is a global indicator of quality of the 
model and it is given as the standard deviation from the mean value. The smaller the 
value, the better is the model evaluated [57]. 
 
 SOLVX  
(http://ekhidna.biocenter.helsinki.fi/solvx/start)  
Computes the solvation profile for a protein structure [58]. The solvation free energy of 
each residue is determined considering its intrinsic solvation free energy and the fraction 
of its non-polar and polar surfaces that are solvent-accessible [58]. An overall solvation 
preference should be below zero, indicating a well-packed structure [59]. The more 
negative the value, the better is the model. 
 
 RMSD (Root Mean Square Deviation) corresponds to the deviation of each aligned pair of 
the backbone atoms between each homology model and the template structure. [60]. It 
was calculated using the superimposition function implemented in PyMOL Molecular 
Graphics System, Version 1.3 Schrödinger, LLC. 
 
 VERIFY3D  
(http://nihserver.mbi.ucla.edu/Verify_3D/)  
Analyzes the compatibility of an three-dimensional model with its aminoacid sequence 
[55]. Each residue is assigned a structural class based on its characteristics (buried area of 
the residue, the fraction of side-chain that is covered by polar atoms, and the secondary 
structure [61]). Each residue is scored according to a protein database, obtaining a 3D-1D 
profile score, ranging from -1 (bad score) to +1 (good score) [55]. 
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3. Molecular Dynamics 
Molecular dynamics (MD) simulations were performed with the Gromacs v.4.5 simulation 
package [62] on a Sun Grid Engine mounted on a high performing computer cluster with 188 
cores. The best evaluated homology models were taken as starting structures. Each system 
was solvated in a truncated octahedral box filled with explicit water molecules, keeping a 
distance between the protein and the box edges of 12Å. The system electroneutrality was 
guaranteed by adding the appropriate number of counter ions. The system was simulated 
using the united-atom force field GROMOS53A6 in an isothermal-isobaric ensemble (NPT), 
coupled to the Berendsen barostat with a reference pressure of 1.0bar and a coupling time 
constant of 0.6ps [63], as well as to the V-rescale thermostat with a reference temperature 
300K and a coupling time constant of 0.1ps [64]. The LINKS algorithm was applied to constrain 
all H-bonds [65] and the electrostatic term was described by using the particle mesh Ewald 
algorithm, as implemented in GROMACS software. An integration time step of 2fs was used 
and the resulting coordinates were recorded on the trajectory every 2ps. 
The MD protocol comprised three main steps. First, the energy of the system was 
minimized through a steepest descent followed by a conjugate gradient algorithm of 2000 and 
1000 steps, respectively. Second, each individual system was equilibrated in three subsequent 
steps for 100ps each, and a decreasing force constant for positional restraint of 1000, 100 and 
10kJ/mol was applied to all protein heavy atoms, in order to relax the system gradually. Third, 
the production phase comprises a fully free trajectory with a certain length. Remaining 
parameters details are described elsewhere [16]. All jobs ran in parallel in the SGE cluster in 
with 8cores per job. 
 
1.2. Ligand Topology Parameterization 
New ligand topologies have to be generated, ensuring a full consistency and compatibility 
with the GROMOS53a6 force field. For this purpose, the online server PRODRG 
(http://davapc1.bioch.dundee.ac.uk/prodrg/) [66] was used to generate new ligand topology 
files. 
 
1.3. Interactions/distance analysis criteria 
Analyzing the resulting MD trajectories allows the characterization of interactions between 
key atom pairs. For hydrogen-bond interactions, the threshold criteria assumed an angle cutoff 
of 20° and a donor-acceptor distance between 2.0-3.0Å [67]. For hydrophobic interactions, a 
threshold of 6.4Å between adjacent aromatic rings [68] was considered. A particular 
interaction was considered significant if it persists 10% or more of the simulated MD time. 
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4. Molecular Docking 
Ligands’ coordinates were sketched on ChemBioOffice 12.0 (CambridgeSoft®) software and 
were docked into the target GFP and tagged-GFP proteins, using the Autodock v.4.2 software 
package [69]. The Gasteiger partial charges and AutoDock atom types were automatically 
assigned to the receptor and ligand pdb coordinate files through the python scripts distributed 
with the software version. A blind docking approach was followed [70]. A Lamarckian genetic 
algorithm was used with an initial population of 150 conformations, a maximum of 2500000 
energy evaluations, a maximum number of 27000 generations, a 0.02 mutation rate, and a 0.8 
crossover rate, a total of 256 independent solutions, a grid size of 130x100x100 (x,y,z) and a 
spacing of 0.5Å. The center of the grid was defined automatically by the software as the 
system center mass. 
Non-specified settings were assumed by default. A RMSD cut-off value of 2.0Å was used in 
the automated cluster analysis of docking results. 
 
4.1. Docking solution analysis criteria 
Docking results were assessed taking into account four criteria: (1) energy criteria – the top-
scoring docking solutions with the best estimated binding free energy were selected; (2) 
geometry criteria – docking solutions leading to ligand interactions in the protein inner cavities 
were discarded; (3) Ka criteria - the estimated affinity constant (Ka) might be comparable to 
the Ka experimentally determined [47]; (4) anchoring point criteria – only solutions where the 
anchoring point to the solid support was exposed to solvent were selected. 
 
 
3.2.2. Experimental methods 
1. Synthesis and characterization of the magnetic supports 
1.1.  Synthesis of coated-MNP 
Dextran- and PEG-coated MNP were synthesized by the co-precipitation method, using 
FeCl3 and FeCl2 salts with a molar ratio of Fe
2+/Fe3+ of 0.5 in a basic and inert environment. A 
solution of 25% ammonium hydroxide in deionized water was purged with N2 gas for 
30minutes. A freshly prepared iron solution (25ml) and the coating solution (80mg/ml, 25ml) 
were added in a dropwise manner, to a total volume of 200ml. The reaction continued under 
an inert atmosphere during 2h. The resulting MNPs were washed with distilled water several 
times with the aid magnetic separation. 
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1.2. Amination of the magnetic supports 
The supernatant of the prepared solution of MNPs is removed and the particles were 
washed twice with 200ml 50%ethanol:50%water and sonicated during 5min. The MNPs 
(10mg/ml) were ressuspended in 20ml APTES (9.4g/ml), 1ml of acetic acid and 179ml 
ethanol:water (50:50). The mixture was incubated for 1h at 70°C with constant shaking. 
Afterwards the solution was washed first with ethanol and then with water. 
 
1.3. Quantification of amines by Kaiser Test 
The Kaiser test is a colorimetric test based on the reaction of ninhydrin with primary 
amines. 50μl of each reagent were added to 1ml of the aminated-supports: 80%phenol in 
ethanol (w/v), 2% 0.001M aqueous solution of potassium cyanide in pyride (v/v) and 
5%ninhydrin in ethanol (w/v). Samples were incubated for 5min at 100°C, and the absorbance 
was measured at 560nm. Calibration curves were obtained using standard solutions of glycine 
(0-5μmol/ml). In this work we have achieved amination contents from 140μmol NH2/g support 
to 428 μmol NH2/g support. 
 
1.4. Characterization of magnetic supports 
To estimate the concentration of the MNP solution containers were weighted before and 
after adding 0.25ml of the MNP solution. The solutions were dried overnight at 60°C and the 
concentration (mg/ml) was determined. 
All magnetic supports have been characterized by dynamic light scattering (DLS) and by zeta 
potential, using 0.05mg/ml solution in deionized water (pH5.80). 
 
2. Production of crude extracts containing GFP and RK-GFP 
2.1. Preparation of Luria Broth (LB) liquid and LB agar medium 
LB medium (25g LB/l distilled water) and LB agar medium (25g LB/l and 15g agar/l) were 
autoclavated at 120°C for 20min. For LB agar containing ampicilin, the liquid was cooled down 
at room temperature (RT) and a final concentration of 100μg/ml of ampicilin was added under 
sterile conditions.  
 
2.2. Transformation of the plasmids pAP001 (GFP) and pAP006 (RK-GFP) in NZY5α competent 
cells  
NZY5α competent cells were used to replicate the plasmids. The fragments DNA shown in 
Figure 3.1a and Figure 3.1b were cloned into pET-21c, resulting in pAP001 (expressing RK-GFP) 
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and pAP006 (GFP). 60μl of cells and 2μl of plasmid were mixed and incubated in ice for 30min. 
Afterwards the solution was subjected to a heat shock during 30s at 42°C, and then incubated 
in ice for 2min. 940μl of LB medium were added to the mixture and it was incubated at 37°C 
for 1h with constant shaking (210rpm). Afterwards, 50μl of the transformed cells were spread 
on LB agar ampicilin plates, which were incubated at 37°C overnight. The negative control was 
performed by not adding any plasmid and the positive control was performed by adding 1μl of 
pNZY28 plasmid. 
 
2.3. Isolation and purification of plasmid DNA (pDNA) 
This procedure was carried out with the DNA isolation NZYMiniprep kit. On the previous 
day, the pre-inoculum was performed by using test tubes containing 6ml of LB medium, 
0.1μg/ml of ampicilin and one colony of the corresponding freshly transformed plate (obtained 
in 2.2), which was incubated overnight at 37°C at 210rpm. The resulting cultures were 
centrifuged for 2min at 11000×g, and the supernatant was removed. The cell pellet was 
ressuspended in 500μl of buffer A1/RNAse by vortexing. 500μl of buffer A2 was added and the 
solution was mixed and it was incubated at RT for 4min. 600μl of buffer A3 was added and 
gently mixed. Afterwards the solution was centrifuged for 10min at 11000×g at RT. The 
supernatant was loaded into a NZYTech spin column placed inside a 2ml collecting tube. It was 
centrifuged 2min at 11000×g and the flow-through was discarded. The spin column was 
washed by adding 500μl of buffer AY, centrifuged 2min at 11000×g, added 600μl of buffer A4 
and centrifuged again. The flow-through was discarded, and the column is centrifuged again 
for 3min at 11000×rpm. For the pDNA elution, the column was placed inside a new collecting 
tube and 30μl of deionized warm water was added to the column and incubated at 65°C for 
1min. The column was centrifuged for 2min at 11000×g and the flow-through corresponded to 
the first elution of pure pDNA. A second elution with 50μl of deionized warm water was 
performed in the same conditions. Finally the plasmid concentration was determined. 
 
2.4. Evaluation of pDNA through agarose gel electrophoresis 
 0.8% agarose gel was prepared by dissolving the agarose in 100ml of TAE pH8.5 (40mM 
Tris-base, 20mM glacial acetic acid, 1mM EDTA) and the solution was poured into the casting 
frame with the comb inserted. The agarose gel was polymerized for 1h and transferred to the 
running module. The tank was filled with TAE and the samples were applied in each well. The 
running conditions were set as 100V for 1h. Afterwards the gel was immersed in the staining 
solution (100ml TAE, 10μl Green Safe) for 30min and the gel was photographed. 
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The solutions for loading were prepared as followed: 2μl of sample or 5μl of the molecular 
weight marker and 5μl of loading buffer (65% sucrose, 10mM Tris-HCl, 10mM EDTA, 0.3% 
bromophenol blue).  
 
2.5. Transformation of BL21(DE3) competent cells  
BL21(DE3) competent cells were used for protein expression of T7 RNA polymerase-based 
systems. The same protocol as in 2.2 was followed, using the pDNA isolated in 2.3.  
 
2.6. Protein expression in BL21(DE3) competent cells 
The previous day, a pre-inoculum was performed as described in 2.2 with the resulting 
transformant colonies from 2.5. After 8-9h of incubation at 37°C (210rpm), 1ml of the culture 
was used to inoculate 50ml of LB medium containing 0.1μg/ml ampicilin. The culture was 
incubated overnight at 37°C (210rpm). The next day, 10ml of the resulting culture was used to 
inoculate 1L of LB medium containing 0.1μg/ml ampicilin, and it was incubated at 37°C with 
constant shaking. The culture growth was monitorized by optical density at 600nm. Once the 
cultures reached OD600nm 0.6-0.8 the protein expression is induced by adding 1ml of IPTG (1M). 
The protein expression was monitorized by GFP fluorescence, OD600nm and SDS-PAGE analysis. 
 
2.7. Cellular fractionation 
After 22h of protein expression, the cell culture was centrifuged (20min, 18000×g at 4°C). 
The ressuspended cells in PBS were subjected to three freeze/thaw cycles. Cell lysis was 
performed by a mechanical process (French Press), with a maximum of 20000psi of pressure 
applied. Afterwards, DNAseI was added, the sample was incubated for 30min in ice and 
centrifuged (15min, 18000×g at 4°C). The resulting pellet was ressuspended in 15ml of PBS and 
stored at -20°C. The supernatant was further ultracentrifuged at 180000×g for 1h30 at 4°C. The 
protein expression was monitorized by GFP fluorescence, OD600nm and SDS-PAGE analysis. 
  
2.8. Sample preparation for SDS-PAGE analysis 
In order to evaluate the amount of protein expression, sample volumes were normalized. 
For the time course samples the normalization was performed according to the ratio 
1.2/OD600nm for each sample. The corresponding volumes were centrifuged 5min at 6800×g 
and the supernatant was discarded. All samples were ressuspended in 20μl of sample buffer 
and boiled for 2min. 15μl of each sample was used to apply in the 12.5% 
acrylamide/bisacrylamide gel (see section 4.1). 
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For the fractionation samples, the normalization was performed relatively to one initial 
volume of one of the samples. 5μl of sample buffer is added to each sample and it was boiled. 
10μl were used to apply in the gel (see section 4.1). 
 
3. Immobilization of specific affinity ligands onto magnetic supports 
The solid phase synthesis of affinity ligands was based on the Ugi mechanism [15] which is 
summarized in Figure 3.2. The Ugi mechanism is a one-pot four-component reaction, with the 
combination of an aldehyde, an amine, an isonitrile group and a carboxylic acid [15]. In this 
work, the aldehyde coumpound used was glutaraldeyde and the isonitrile group was provided 
by isopropyl cyanide.  
 
 
Figure 3.2 - Ugi reaction mechanism. 
The amine and carboxylic acids used for this reaction are shown in Table 3.1 and 
correspond to the compounds necessary to synthesize the lead ligands for GFP and RK-GFP, as 
well as the ligands showing the worst binding affinity (employed here as negative controls) 
[47]. 
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Table 3.1 - Amine (on the left) and carboxylic acid (on the right) compounds used for the Ugi reaction, for ligands 
LA-A4C7, NA/LR-A7C1 and NR-A5C2, respectively.   
Amine compounds Carboxylic acid compounds 
A4 
1-pyrenemethylamine hydrochloride 
 
C7 
phenylacetic acid 
 
 
A7 
aminoisophtalic acid 
 
C1 
succinamic acid 
 
A5 
4-aminobenzamide 
 
C2 
3-(4-hydroxyphenyl)propionic acid 
 
 
 
The aminated magnetic supports were firstly fucntionalized with aldehyde groups. After 
removing the water, 30ml of 10mg/ml aminated dextran-coated MNPs (MNP_DEX_NH2) were 
ressuspended in 5% (v/v) glutaraldeyde in a basic environment (5.4ml NaOH 1M).  The mixture 
was incubated 1h at 30°C. Afterwards the solution was washed five times with 30ml of 
deionized water. 
The next step was to add the corresponding amine compound dissolved in 10ml methanol 
in a 5-molar excess to the amines of the support. Amines with carboxylic functionalities (e.g. 
HCL 
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A7) or protected by HCl (e.g. A4) were pre-treated with NaOH, in the same molar amount as 
the species in solution. The mixture was incubated for 2h at 60°C. Afterwards 5-molar excess 
of the correspondent carboxylic acid in 10ml methanol and 5-molar excess of isopropyl cyanide 
were added to the solution and the mixture was incubated for 48h at 60°C. 
The particle slurry was washed twice in 100% methanol, twice in 50%DMF:50%methanol, 
once with water, twice with 0.2M NaOH in 50% isopropanol and finally twice in distilled water.  
 
3.1. Screening crude extracts with the functionalized magnetic supports 
The methodology is summarized in Figure 3.3. In each assay, non-functionalized 
MNP_DEX_NH2, MNP_DEX_NH2 functionalized with the best ligand and MNP_DEX_NH2 
functionalized with the worst ligand were tested. Previously the supports are washed with 1ml 
of the following solutions: 0.2M NaOH in 50% isopropanol, deionized water, PBS (10mM 
sodium phosphate, 150mM NaCl, pH7.4). All tests were performed in duplicates. 
The loading solution was incubated for 15min at 4°C with each magnetic support. The 
supernatants were collected (fall through - FT) and the supports were washed with PBS by 
means of centrifugation (5min, 1850×g) and an external permanent magnet. 
Each magnetic support was then divided into two aliquots, on which two different elution 
conditions were tested. The best two elution conditions were determined in a previous study 
[47]: for GFP purification, 0.1mM glycine-NaOH pH9 and 0.1mM glycine-NaOH pH9 50% (v/v) 
ethylene glycol; for RK-GFP purification,  PBS pH 7.4, 500mM arginine and 0.1M glycine-NaOH 
pH 11, 150mM NaCl. Each sample was washed five times with 1ml of the elution buffer. 
All supernatants were recovered and stored at 4°C and protected from light until 
quantification. Each sample was quantified through GFP fluorescence and by BCA colorimetric 
assay. An example of each duplicate was also analyzed by SDS-PAGE. 
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Figure 3.3 - Schematic representation of the methodology followed to test the magnetic supports with the different 
crude extracts. Each assay was performed using MNP_DEX_NH2, MNP_DEX_NH2 functionalized with the best ligand 
(in grey) and MNP_DEX_NH2 functionalized with the worst ligand (in red). 
 
3.2. Static partition equilibrium studies 
Previously the needed volume of MNP solution is washed twice in 0.2M NaOH in 50% 
isopropanol and twice in PBS. A volume of 500μl from different concentrations of crude extract 
containing GFP or tagged-GFP in PBS were incubated with the 500μl of MNPs (40mg/ml) 
functionalized with the corresponding affinity ligand. The interaction was promoted over 12h 
at 4°C to achieve chemical equilibrium. Afterwards the supernatant was collected and the 
fluorescence intensity was measured. The adsorption phenomenon followed a Langmuir 
isotherm and the experimental data was fitted accordingly with OriginPro (v8.5.1). 
 
3.3. Sample preparation for SDS-PAGE analysis 
5μl of sample and 5μl of sample buffer were boiled for 2min and all sample was applied to 
the previously polymerized 12.5% acrylamide gel (see section 4.1). 
 
3.4. Data analysis: selectivity, percentage of recovery, yield and purity 
The results obtained for both systems (LA-A4C7/GFP and LR-A7C1/RK-GFP) have been 
analyzed according to selectivity (Equation 3.1), percentage of recovery (Equation 3.2) and 
yield (Equation 3.3). The purity of the eluted fraction has been calculated by the ImageLab4.1. 
software. 
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3.5. Fluorescence studies with ligand LA-A4C7 
The amine of LA-A4C7 is 1-pyrenemethylamine which has a fluorescence signal in the same 
wavelength as GFP (λexcitation=485nm and λemission=535nm). This study had two objectives: (1) 
confirm the presence of the pyrene molecule in the MNP functionalized samples, and (2) 
confirm that there is no pyrene (ligand) leaching during the testing of the functionalized 
magnetic supports with crude extracts.  
For the first goal, fluorescence microscopy was applied for a qualitative analysis of the 
magnetic beads before and after functionalization with the Ugi reaction employing 1-
pyrenemethylamine as amine. Briefly, the MNP solution (10mg/ml) was analyzed by 
fluorescence microscopy by placing the solution in a glass microscope slide for observation. 
For the second goal, the protocol described in Figure 3.3 was used, using the same volume 
of PBS instead of the crude extract and 40mg/ml of magnetic support. The fluorescence 
intensity of the collected samples was analyzed by spectrofluorimetry on 96-well plates. 
 
4. Protein quantification methods 
4.1. SDS-PAGE preparation and staining 
12.5% acrylamide/bisacrylamide SDS-PAGE gels were used in this work. The volumes of 
each solution used to prepare the gels are shown in Table 3.2. The running gel was prepared 
first and the solution was transferred to the glass plates of the casting frame. 1ml of 2-butanol 
was added on the top of the gel solution, and the gel was polymerized for 30min. Afterwards 
the 2-butanol was removed and the gel was washed with distilled water. The 5% acrylamide 
stacking gel was prepared and the mixture was added on top of the previous one. The comb 
was inserted and the gel was polymerized for 30min. The electrophoresis buffer (0.25M Tris-
Base, 1.92M glycine, 0.1% SDS pH8.3) was added to the tank and the polymerized gel was 
introduced in the running module. The samples prepared previously were applied in each well. 
The running conditions were set as 150V for 1h. 
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Table 3.2 - Volumes necessary to prepare a 12.5% acrylamide gel for SDS-PAGE. 
Stacking gel 
 V (ml) 
Solution I (3M Tris Base pH 8.8) 0.75 
Solution III (30% acrylamide and bis-acrylamide solution 19:1) 2.08 
10% SDS 0.05 
Distilled water 2.1 
APS 0.038 
TEMED 0.0025 
Running gel 
Solution II (0.5M Tris Base pH 7.0) 0.450 
Solution III  0.3 
10% SDS 0.018 
Distilled water 0.94 
APS 0.0135 
TEMED 0.002 
 
4.1.1. Blue-Coomassie staining 
The SDS-PAGE gel was transferred into the staining solution (1g Coomassie Blue R-250, 
15ml glacial acetic acid, 90ml methanol and 95ml distilled water) for 30 min. Afterwards the 
gel was destained overnight with the destaining solution (75ml glacial acetic acid, 450ml 
methanol and 475ml distilled water). 
 
4.1.2. Silver staining 
The gel was transferred into the fixative enhancer solution (50%methanol, 10%acetic acid, 
10%fixative enhancer concentrate, 30%distilled water), and incubated for 20min with gentle 
agitation. Afterwards the gel was rinsed twice in 400ml of distilled water for 10min. The 
staining solution (5ml silver complex soluion, 5ml reduction moderator solution and 5ml image 
development reagent, 50ml development accelerator solution) was prepared within 5min of 
use, and the gel incubated for 20min. The final step involved the incubation of the gel in a 5% 
acetic acid solution to stop the previous reaction. The gels were rinsed in deionized water. 
 
 
 
   3. MATERIALS AND METHODS 
 
33 
 
4.2. Quantification of GFP and total protein 
The GFP fluorescence allows the quantification of GFP and tagged-GFP by pipetting 200μL 
of each samples in a 96-well microplate and measuring the fluorescence intensity 
(ʎexcitation=485nm and ʎemission=535nm). A calibration curve was obtained using a pure GFP 
solution (10-6-10-1mg/ml). PBS was used as blank. 
The total protein was quantified through the colorimetric BCA assay. The BCA reagent was 
prepared by adding 50 parts of reagentA (bicinchoninic acid, sodium carbonate and sodium 
bicarbonate in 0.1N NaOH pH11.25) with 1 part of reagentB (4% (w/v) copper(II) sulfate 
pentahydrate). 25μl of each samples were added to each well in a transparent 96-well 
microplate, followed by the addition of 200μl the freshly prepared BCA reagent. The 
microplates were incubated at 37°C during 30min and the absorbance at 560nm was 
measured. A calibration curve was obtained using a solution of BSA (0-1mg/ml). 
5. Preparation and testing of magnetic antimicrobial devices 
5.1. Immobilization of Cys-(RW)3 antimicrobial peptide by sulfo-coupling 
The sulfo-coupling strategy (Figure 3.4) was used to immobilize the peptide Cys-PP-
RWRWRW onto the magnetic supports (dextran-, silica-dextran- and PEG-coated MNP) using 
sulfo-SMCC as an amine-to-sulfhydrl crosslinker. Each support was previously washed five 
times with conjugation buffer (10mM phosphate, 150mM NaCl, 1mM EDTA, pH7.2 purged with 
N2) after which the supernatant was discarded. Five-molar excess of sulfo-SMCC to the amines 
of the support in 1ml distilled water was added to the support and incubated for 30min at RT 
with constant shaking (200rpm). One-molar excess of peptide to the amines was added, the 
mixture was incubated for 1h at RT and it was washed 10 times with 1ml of conjugation buffer. 
100mM of cysteine is added to the particle slurry. The mixture was incubated 1h at RT with 
constant shaking. Between reactions the mixture was always washed several times with 
conjugation buffer and the supernatants were collect and further analyzed. 
34 
 
 
Figure 3.4 - Schematic representation of the functionalization of aminated coated-MNP with the peptide Cys-PP-
RWRWRW by Sulfo coupling. 
 
5.2. Immobilization of (RW)3 antimicrobial peptide by EDC-coupling 
The EDC-coupling (Figure 3.5) was used to immobilize the peptide RWRWRW onto the 
magnetic supports (PEG-coated MNP) via carbodiimide activation. Each support was previously 
washed with PBS buffer five times and the supernatant was discarded. 1ml of distilled water 
was added to the magnetic support after which all reagents (peptide, EDC and NHS) were 
added simultaneously with a 1:1 molar excess to the amines of the support.  The mixture was 
incubated for 2h at RT with constant shaking. Afterwards, the support was washed with PBS 
buffer and the supernatants were collect to quantify the immobilization yield. 
 
   3. MATERIALS AND METHODS 
 
35 
 
 
Figure 3.5 - Schematic representation of the functionalization of aminated coated-MNP with the peptide RWRWRW 
by EDC coupling. 
 
5.3. Quantification of peptide immobilization and peptide characterization 
The percentage of immobilization was calculated by Equation 3.4, by taking into account 
the measurement of the fluorescence of the initial peptide solutions (total protein added) and 
in the collected supernatants during the washes (total protein washed). The tryptophan 
present in the peptide can be measured through fluorescence intensity using ʎexcitation=280nm 
and ʎemission=340nm. Calibration curves were obtained with the respective pure peptide (0-
1mg/ml). 
 
                 
                                                
                        
                     ) 
 
Furthermore, both peptides described above have been characterized by the zeta potential 
(0.05mg peptide/ml). 
 
5.4. Antimicrobial assays with the antimicrobial magnetic devices 
The strains used to test the antimicrobial magnetic devices were E. coli K12 and B. subtilis 
168. Two methods have been tested (Figure 3.6): (a) shaking flasks for a total of 5mL of 
culture, and (b) 96-deep well titer plate for a total of 2mL of culture. The pre-inoculum of the 
bacteria were prepared by growing strains in LB medium at 37°C with constant shaking 
(300pm) overnight. The next day the cultures were diluted until reaching OD600nm of 0.045. The 
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cultures were then incubated (37°C, 300rpm) and when the cultures reached an OD600nm 
between 0.1-0.15, 10% volume/volume of magnetic support and/or antimicrobial agent was 
added to the culture. The OD600nm was recorded each 30min until the end of the assay (the 
MNPs were removed from solution using an external permanent magnet recording the 
absorbance). All assays were carried out in triplicates. 
 
Figure 3.6 - Schematic representation of the antimicrobial assay. 
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4.1. Objective 
Experimental techniques for the determination of three-dimensional structure proteins 
have contributed for the deposition of over 94000 protein structures in the PDB [71]. However 
the determination of the structure of all protein-ligand complexes experimentally at high 
resolution is still an impossible task [71]. Hence, reliable computational methods are of 
increasing importance.  
In this work, the aim was to unveil the possible binding location and main interactions of 
the affinity pairs previously found [47], namely LA-A4C7 with the protein GFP and ligand LR-
A7C1 with the protein RK-GFP. For that purpose we have combined homology modeling, 
molecular dynamics and automated docking to predict the docking location and main 
interactions between the affinity pairs.  
 
 
4.2. In silico study of affinity ligands for the purification of GFP 
The first step to structurally characterize the system developed in [47], was to have an 
accurate structure of the GFP used in this work. 
GFP was first isolated from the jellyfish Aequorea victoria. The fluorescent properties of this 
protein make it a perfect candidate to be used as a reporter for recombinant gene expression 
[72] and it has been used to follow the expression of recombinant proteins in E. coli [47]. The 
solution’s fluorescence is directly proportional to the amount of protein being expressed and it 
is a reliable method for protein quantification [73].  
 
The GFP is a 238 aminoacid polypeptide [74] constituted by a β-barrel fold of eleven strands 
forming an almost perfect cylinder of about 25Å in diameter and 40Å tall [75]. The protein is 
capped at both ends, isolating the central chromophore from solvent [74]. A graphical 
representation of the GFP secondary structure is shown in Figure 4.1. 
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Figure 4.1 – Schematic representation of Aequorea victoria GFP secundary structure. The β-sheets are numbered 
and represented as dark green cilinders with an arrow pointing towards the C-terminus. The α-helices are 
represented as light-green cilinders. The loops that link the β-sheets are represented as green full lines.  
 
There has been an effort to develop engineered variants of GFP with various optimized 
experimental properties (see Shaner et al and references within [76]). Until 2011, there were 
250 different structures of GFP deposited in the PDB [77]. 
 
4.2.1. Homology modeling 
The first system modeled was GFP (non-tagged system). The nucleotide and aminoacid 
sequences corresponding to the GFP used in this work are shown in Figure 3.1a, in the 
Methods section.  
 
The first step was to identify high identity-sequences for template selection. NCBI BLASTp 
was used to search for homologous templates. ExPASy SIM and EMBL-ebi ClustalW were used 
to perform the alignments of protein sequences. The parameters were used as default. The 
results obtained are shown in Figure 4.2 and summarized in Table 4.1.  
The GFP aminoacid sequence used was confirmed within the GFP superfamily. Despite the 
variety of GFP structures deposited in the PDB, none had a 100% protein sequence identity 
with the target sequence. These differences are based on some point mutations (see Figure 
4.2).  
4. IN SILICO STUDY OF AFFINITY PAIRS FOR PROTEIN PURIFICATION 
 
41 
 
 
Table 4.1 - Top ranking sequence alignment, using the GFP sequence of this work as query in the search.  
PDB ID Resolution (Å) 
Sequence 
Identity (%) 
4GES 1,23 99,2 
1GFL 1,90 98,7 
1YHI 1,90 98,3 
1QYO 1,80 98,3 
1EMG 2,00 98,3 
1EMA 1,90 98,3 
2WUR 0,90 97,9 
 
 
 
Figure 4.2 - Alignment results obtained by the webserver tool ClustalW (EMBL-ebi) using the protein sequence of 
GFP as query. * (asterisk) indicates positions which have a conserved residue; : (colon) indicates coservation 
between groups of strongly similar properties; . (period) indicates conservation between groups of weakly similar 
properties. Gap indicates no conservation between residues. 
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As there was no available structure for the target protein sequence, other strategy had to 
be used. Homology modeling refers to the construction of a three-dimensional model of a 
protein structure (target) based on the sequence similarity with family-related ones, from 
which the structure is known (template) [49]. This strategy has been used successfully by other 
authors to generate models of protein structures that are not available (e.g. [78,79]). 
Protein homology modeling is characterized by four general steps: (1) identifying suitable 
templates, (2) pairwise sequence alignment between the amino-acid sequences of the target 
and the putative templates, (3) building the model, and (4) evaluating the quality of the results 
[80].  
Poor target-template alignments, structural flexibility, low template quality or inaccuracies 
introduced by the modeling program can influence significantly the accuracy of the excepted 
model [49]. If the resulting model is not satisfactory, some or all of the steps can be repeated 
iteratively in order to obtain a better one [81]. 
 
Thus, homology modeling can only generate a model as good as the chosen template, 
which makes the availability of homologous templates a critical bottleneck of this approach 
[49]. Insertions, deletions, among other genetic modifications might cause significant 
structural changes and should be avoided by a careful choice of the template [49]. Homology 
modeling is known to give quite accurate results for target-template pairs sharing more than 
40% sequence identity [55] and all results from the alignment tools (Table 4.1) resulted in high 
sequence identities (>97%).  
 
The algorithm and associated energy function used for the homology modeling task depend 
on the software chosen. In general, most software packages start to assign the coordinates of 
aligned amino acid positions from the backbone atoms retrieved from the template structure 
or by using this information to generate spatial restraints [80]. Modeling unaligned regions 
requires different tactics, which differ from software to software [80]. Four different homology 
modeling software were used, namely: (1) SWISS-MODEL, (2) Chimera-Modeller, (3) Rosetta 
and (4) I-TASSER. All predicted models that have resulted from this task are shown below, in 
Figure 4.4. The models were chosen to proceed with the modeling task according to the 
evaluation scores (crystallographic resolution of the chosen template, available information 
about the template’s structure, RMSD from the template structure, ANOLEA, GROMOS, 
QMEAN, SOLVX and VERIFY3D). The evaluation results of the homology modeling task are 
shown in Table 4.3, at the end of this section. 
4. IN SILICO STUDY OF AFFINITY PAIRS FOR PROTEIN PURIFICATION 
 
43 
 
 
SWISS-MODEL 
The methodology used by this software is modeling by rigid-body assembly [82], which 
constructs the model from a few core regions, loops and side chains retrieved from accessing 
information on related structures [81]. The main limitation of this method is the dependency 
of model accuracy on a good alignment – gaps in the target-template pairwise alignment result 
in poorer models. 
 
The server could only recognize 1EMA and 1QYO as template structures. As 1EMA shared 
less percentage of identity and did not have an associated structure for the last nine 
aminoacids at C-terminal, 1QYO was selected as template. 
The structure of 1QYO (Figure 4.3) is one of the few GFP structures deposited in the PDB 
that has an associated secondary structure for the C-terminal residues (Figure 4.3, in red). The 
result of the homology modeling task (GFP_SM) is shown in Figure 4.4a superimposed to the 
1QYO structure. A good indicator of homology modeling accuracy is given by the estimated 
RMSD between the template structure and the homology model. The higher is the RMSD value 
the worse is the homology model [55]. The rigid body assembly modeling method used by 
SWISS-MODEL [82] results in a small RMSD of 0.050Å, between the template backbone heavy 
atoms of the structure and the predicted homology model structure.  
 
 
 
 
 
 
 
 
 
This homology model scored the best ANOLEA profile and a good score by GROMOS 
accuracy indicator. The SOLVX scored indicates this model as a well packed structure, with a 
score of -133.7. The SWISS-MODEL model for GFP had the best QMEAN score regarding all-
atom interaction, solvation and torsion terms. However this was the model that had the worst 
Figure 4.3 - Crystallographic structure of the S65G Y66G GFP variant (PDB ID: 1QYO). The backbone structure is 
colored blue beginning at the N-terminal to red at the C-terminal of the structure. Displayed using cartoon 
representation in PyMol. 
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VERIFY3D result, being the model with the least agreement between its aminoacid sequence 
and its 3D atomic model. The residues scored as “very bad” (scores below 0) are concentrated 
mainly at the C-terminus. This is in agreement with a poor score for the secondary structure 
agreement term in QMEAN. For further information, consult Table 4.3. As the evaluation 
criteria were not as good as the ones obtained with other modeling software, this model was 
discarded. 
 
Chimera Modeller 
Modeller software package implements an automated approach to homology modeling by 
satisfaction of spatial restraints [82].  
Modeller generated five models for each template, ordered by RMSD (Table 4.2). It is clear 
that the best solution (GFP_s1M, Figure 4.4b) was obtained for the 1QYO template which had 
the most completed sequence information. This is a consequence of the homology modeling 
module implemented by Modeller [83]. Accordingly, the worst model in terms of RMSD was 
obtained when using 1YHI, the template with more unstructured terminals and missing 
residues. 
 
Table 4.2 - Best solution obtained by Chimera’s Modeller tool for each template used for GFP. The solutions are 
ordered by the corresponding RMSD and some extra remarks are given. 
 
 
 
 
 
 
 
 
[1] The best for the given template. 
[2] Worst solution for the given template. 
 
The resulting best model (Figure 4.4b) has a secondary structure associated with the last 
residue in C-terminal, according to the used template.  
The obtained RMSD between the template and the resulting model was higher (0.909Å) 
than for the SWISS-MODEL model, which is a direct result of the different homology modeling 
algorithm employed by Modeller. The consideration of extra spatial restraints by the modeling 
software [82] results in a homology model that differs more from its starting template. 
Although less residues are in a favorable energy environment when scored by ANOLEA 
Template RMDS (Å) 
Aminoacids 
missing 
1QYO [1] 0.909 1 
4GES 1.021 7 
1GFL 1.288 8 
1YHI [2] 3.664 10 
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(93.70%), this is even more evident when analyzing the GROMOS scores (only 49.22% spread 
along the sequence are in a favorable energy environment). However the VERIFY3D results are 
overall better than for the SWISS-MODEL homology model. The Modeller homology model was 
the model that was best scored in terms of the overall QMEAN score - for further information, 
consult Table 4.3. Therefore, this model GFP_s1M (Figure 4.4c b) was selected for the 
following modeling steps. 
 
Rosetta 
Rosetta’s homology modeling approach is based on three steps: (1) built an incomplete 
model structure based on the alignment between the target sequence and a chosen template, 
(2) complete the missing structure using loop modeling and (3) rank or evaluate the energy of 
the resulting structural models [84].  
 
1QYO was chosen as the homologous template and it was possible to obtain one homology 
model for GFP (GFP_R, Figure 4.4c). When compared to the 1QYO structure, a very low RMSD 
value of 0.003Å was obtained, the lowest for the evaluated homology models. 
This model had the best SOLVX score (-138.7) and was well evaluated according ANOLEA 
and GROMOS. The VERIFY3D score showed a low percentage for residues with no agreement 
with their expected 3D atomic model, mainly concentrated in the C-terminus. The VERIFY3D 
profile is very similar to the one obtained for the homology model for GFP predicted by 
Modeller. This model GFP_R (Figure 4.4c) was also took into account in the following modeling 
steps. 
 
I-TASSER 
I-TASSER is a webserver that allows homology modeling. This software combines various 
techniques as threading, ab initio and atomic-level refinement to built an accurate homology 
model [85]. 
The best model obtained by the I-TASSER server was GFP_IT (Figure 4.4d). As shown, there 
is no associated secondary structure to the C-terminal residues, differing from the previously 
described homology models of GFP. This can be explained since 1QYO was not selected as 
template by the I-TASSER software.  
I-TASSER does not allow the user to chose the template that is selected [85] and it selects 
multiple homologous templates simultaneously, all corresponding to PDB entries for 
fluorescent protein structures or GFP-fusion proteins. This set is identified by the LOMETS 
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threading programs and correspond to a representative PDB subset with a pair-wise sequence 
identity cutoff of 70% [85]. The protein structures chosen as templates by the software 
(consult Table 4.3) were not identified previously as good alignment results (see Table 4.1). 
This homology model had the worst scores regarding ANOLEA and GROMOS, with 
unfavorable energy residues spread along the sequence. However this homology model had 
the best overall VERIFY3D results, although the worst values were still focused on the C-
terminal residues. This is in agreement with the best secondary structure agreement term of 
QMEAN - for further information, consult Table 4.3. As it was the only model with an 
unstructured C-terminal this homology modeling solution was discarded. 
 
Table 4.3 reports to the homology modeling evaluation results for the models described 
above. 
 
Selected homology models for GFP 
All predicted homology models are shown in Figure 4.4. As described above, only two of the 
obtained homology models for GFP were chosen to proceed with the modeling task: GFP_s1M 
(Figure 4.4b) and GFP_R (Figure 4.4c), shown with the same orientation for better comparison. 
 
Figure 4.4 - Best Homology models obtained for GFP using (a) SWISS-MODEL, (b) Modeller, (c) Rosetta, and (d) 
I_TASSER. Only the models (a) and (c) were chosen to carry out the modeling task. The backbone structure is 
colored in gradient from blue (at N-terminal) to red (at C-terminal) of the structure. Two helix structures are 
highlighted with arrows. Displayed using cartoon representation in PyMol.  
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Table 4.3 -  Summary of the comparative homology modeling evaluation for the homology models obtained for the GFP amino acid sequence. The best result for each score is highlighted in 
green 
 
Template 
Sequece 
identity 
ANOLEA 
[1] 
GROMOS 
[2] 
RMSD 
(Å) 
SOLVX 
VERIFY3D 
[3] 
QMEAN 
 
Overall 
Score 
Cβ 
interaction 
All-atom 
interaction 
Solvation Torsion 
Secondary 
structure 
agreement 
Solvent 
accessibility 
agreement 
SWISS-
MODEL 
1QYO 98.31%  99.58% 81.00% 0.05 -133.7 
5.04% 
11.34% 
-0.54 -1.47 -1.51 0.3 -0.39 0.96 1.29 
Modeller 1QYO 98.31%  93.70% 49.22% 0.909 -127.9 
6.30% 
4.62% 
0.36 -1.58 -1.68 -0.12 -1.46 0.71 1.06 
Rosetta 1QYO 98.31%  100% 73.95%    0.003 -138.7 
4.62% 
10.50% 
0.7 -1.45 -1.56 0.34 -0.8 0.78 1.21 
I-TASSER 
1B9C, 
3NED, 
1KYP, 
2JAD, 
3U8P, 
2VZX, 
3CGL 
[4]  50.43% 22.48% [5] -124.2 
2.10% 
5.04% 
-0.96 -2.19 -2.48 -0.31 -4.42 0.06 0.98 
[1] Percentage of residues that were scored positively (>0) by the ANOLEA score. 
[2] Percentage of residues that were scored positively (>0) by the GROMOS score. 
[3] Percentage of residues that were scored as bad (0-1.1; first line) and very bad (<0; second line) by the VERIFY3D score. 
[4] It was not possible to calculate the sequence identity to the group of templates chosen by I-TASSER. 
[5] RMSD value was not calculated due to template selection by the I-TASSER webserver. 
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As shown in Figure 4.4, the two selected homology models have a very similar structure and 
highly conserved folding and packing. The main differences are (1) the orientation of the C-
terminal residues (in red); (2) the length of the helix structure in the N-terminal; (3) the subtle 
difference in orientation and length of some of the loops between the beta sheets; (4) the 
length of the helix highlighted by the green arrow; and (5) the presence of a helix structure in 
the yellow-colored loop in GFP_R. 
The interest of proceeding with both models in parallel concerns a systematic search for 
eventual structural inconsistency and to avoid any computational bias.  
 
Despite extensive optimization of known homology modeling software, there is still a 
considerable uncertainty and source of error in the automated estimation of protein three-
dimensional structure and its quality evaluation. Though, whenever it is possible, the final 
evaluation should be experimentally validated through mutagenesis experiments, affinity 
labelling, NMR dipolar coupling, cryo-electron microscopy [85]. 
  
4.2.2. Structural relaxation of homology models 
Selected protein models have to be relaxed through MD methodologies, in order to take 
into account the dynamical aspects of recognition and binding mechanisms observed in Nature 
and to avoid any structural clash or unphysical structural constraint due to computational 
artifacts.  
 
In classical MD simulations it is possible to derive the time-dependent random movement 
of a protein system along its characteristic potential energy landscape for a given temperature 
and pressure by integrating the Newton’s equations of motion step-by-step [86]. This asset of 
differential equations [87] describe the net force applied on each particle by the atomic 
environment and the particles’ positions and correspondent velocities [88]. 
MD idealizes the system as spherically symmetric separate point particles [88] and the 
kinetic energy is randomly distributed by all the system’s particles, in order to obtain an initial 
velocity. However particles are interconnected through covalent bonds with fixed lengths and 
stiffness [86,87] and interacting with non-bonded neighbors through van der Walls and 
Coulomb-type electrostatic interaction terms that sum up into the energy function [86]. The 
energy function is based on a force field, which described the mechanical behavior of each pair 
of interacting atoms in the system. The potential energy is described in terms of cumulative 
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energy terms [88]. The commonly used force fields for proteins are CHARMM [89], AMBER 
[90], and GROMOS [91]. 
The GROMOS96 53a6 force field, the one used in this work, has been parameterized and 
optimized to work with biological systems, specifically proteins in solution [92]. A simulation of 
10ns length was analyzed and the results are summarized in Figure 4.5 for GFP_s1M and in 
Figure 4.6 for GFP_R.   
 
By Figure 4.5a, one can see that the helix structure which was associated with the C-
terminal residues of GFP_s1M was replaced by an unfolded structure, remaining exposed to 
the solvent. The same phenomenon occurred to the helix highlighted by the blue arrow in 
Figure 4.4a. The GFP protein has a very stable β-barrel core structure [75] and stable systems 
in MD usually display RMSD values between 1.0-2.0Å [78]. Figure 4.5c shows that the major 
flexibility is conferred by the C-terminal residues (232-238) which have the highest RMSF 
deviation (RMSF values between 0.5-2.0Å are quite common in MD studies for proteins around 
equilibrium [78]). This contribution is reinforced through the representation of the high B-
factors corresponding to the C-terminal residues (Figure 4.5d, in red) – high B-factors 
correspond to high flexibility [93]. This is due to the unfolding of the modeled C-terminal helix 
structure.  
 
 
Figure 4.5 - Results obtained after the first MD simulation for the GFP_s1M. a) Superimposition of the model 
obtained by Modeller before MD simulation (in green) and after MD simulation (in blue). b) Variation of the RMSD 
values along the MD simulation trajectory. c) RMSF values per residue. d) B-factor representation of the structure 
flexibility colored in gradient. Blue represents residues with less flexibility and red represents residues with more 
flexibility average over the entire trajectory. 
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GFP_R had a very similar MD profile to the model from Modeller (Figure 4.6).  The helix 
structure of the N-terminal residues did not persist and the C-terminal residues remain with no 
associated secondary structure. Contrary in GFP_s1M, the C-terminal residues stopped being 
so solvent-exposed. Both helix structures, highlighted by the yellow and blue arrows in Figure 
4.4b, did not show any resilient secondary structure. In Figure 4.6b one can see that the RMSD 
profile is similar to the GFP_s1M model on the first 2ns of simulations, correspondent to the 
equilibration phase. The conformation of C-terminal tends to interact with the protein surface 
and the protein continued to search for a more stable conformation, reaching a higher RMSD 
plateau. As described before, the major contribution is due to the flexibility of the C-terminal 
residues, resulting in the high corresponding RMSF values and B-factors (Figure 4.6c and Figure 
4.6d, respectively).  
 
M
 
Figure 4.6 - Results obtained after the first MD simulation for the GFP homology model obtained by Rosetta. a) 
Superimposition of the model obtained by Rosetta before MD simulation (in green) and after MD simulation (in 
blue). b) Variation of the RMSD values along the MD simulation trajectory. c) RMSF values per residue. d) B-factor 
representation of the structure flexibility colored in gradient. Blue represents residues with less flexibility and red 
represents residues with more flexibility average over the entire trajectory. 
Obtained results confirmed the need for a pre-equilibration MD step before docking. 
 
4.2.3. Automated molecular docking 
Protein docking predicts the ideal structural complementarity between two molecular 
surfaces [71]. The main goal of protein docking is to predict how a pair of molecules interact 
[71], predicting accurate ligand poses based on the maximization of the binding energy [16]. It 
explores the conformational available space and calculates the free energy of binding of each 
conformation to identify the minimum energy conformation [94]. 
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To successfully predict a suitable target/ligand complex there are three steps: (1) have 
accurate structures of the molecules involved in the interaction, (2) conformational sampling 
to find the location of the binding site, and (3) determination of the binding mode and energy 
evaluation [70]. The success of a docking software depends on two components: the search 
algorithm, and the scoring function [95]. The combination of these two components will 
dictate the overall results of the docking task. 
 
The relaxed structures of GFP (GFP_s1M and GFP_R) were used to study the potential 
binding modes of the lead ligand LA-A4C7 and the negative control NA-A7C1. This study was 
performed using automated molecular docking tools. Protein docking requires the structures 
of the elements that form the complex and aims to predict correctly the binding site on the 
target and the orientation of the ligand. At the end, a rank of possible docking poses based on 
estimated binding affinities is given [96].  
Regarding GFP, the coordinates of the lead ligand LA-A4C7 (Figure 4.7a) and the negative 
control ligand NA-A7C1 (Figure 4.7b) were set up based on previous experimental solid phase 
affinity results of the complex [47]. The value of the constant affinity (Ka) that was 
experimentally determined for the affinity system GFP/LA-A4C7 was 2.38×105M-1. 
 
Figure 4.7 - Molecular structures of the solid phase screened ligands for GFP system [47]. a) Lead ligand with the 
best affinity, and b) negative control ligand with the worst affinity for GFP system. The chemical group used to 
immobilize the ligand into the solid support is highlighted in red. 
 
Autodock [69] was the docking program package used for the docking task in this work as it 
allows a robust and accurate docking procedure at a reasonable computational demand [69].  
The Lamarckian genetic algorithm is used by default in the Autodock software package. 
Based on the analogy with the concept of natural genetics and biological evolution [69], its 
goal is to “evolve” previous conformations into new low energy conformations. Each docking 
pair is represented by a conformation that is described as a “gene” that has a particular energy 
and the entire “genome” is a representation of the energy landscape which will be explored. 
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Similar to biological evolution, random pairs of individuals are “mated” using a process of 
crossover and there is also the possibility of a random mutation in the “offspring” [69]. During 
each iteration, high-scoring features in the current “generation” are preserved in the next 
cycle [96]. This approach allows exploring large conformational spaces in a more efficient 
manner. 
The AutoDock scoring function [95] is a semi-empirical free energy force field scoring 
function that evaluates conformations and calculates the ligand-receptor binding affinity [97] 
[98]. The calculation of the estimated free energy of binding is based on its components: 1. 
final intramolecular energy, which is divided into (1.1.) van der Waals, hydrogen bond and 
desolvatation energy, and (1.2) electrostatic energy; 2. final total internal energy; 3. torsional 
free energy; and 4. unbound system’s energy [95,98]. The estimated free energy of binding is 
estimated as: 1+2+3-4 according to the energy function implemented in Autodock. 
 
Some settings were altered as described in the Methods Section. Changed parameters were 
(1) the number of runs (256), (2) the number of points of the grid (130 100 100) and (3) the 
grid spacing (0.5). The number of runs corresponds to the number of docking solutions. Higher 
population values result in a better sampling of the conformational spacing, increasing the 
probability of finding a better docking pose, on the expenses of allocated computational time. 
The size of the grid defines the three dimensional area to be explored by the ligand and its 
value can be tuned by altering the number of points and/or the spacing between the grid 
nodes. Both these variables correlate with the accuracy of the search and on the final 
prediction of the best binding solutions. Although a finer grid (a larger number of points and 
/or less spacing between grid nodes) would be advantageous for the quality of the docking 
results, it would increase the memory requirements and processing time [70].  At this stage, it 
was decided to do a blind docking – the search of conformational space is not biased into a 
particular location of the protein structure where there are evidences of a specific binding. For 
that purpose, the docking and grid parameters file were optimized to include all the protein 
surface in the searching area. 
 
The criteria followed for choosing the best results have been described in the Methods 
section. 
 
Docking results of the lead candidate (LA-A4C7) 
The results for the affinity system GFP/LA-A4C7 are summarized in Table 4.4.  
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Table 4.4 - Summary of the docking results for the affinity system GFP/LA-A4C7. 
Target 
protein 
Cluster 
Rank 
Number of 
solutions 
per cluster 
Model 
Solution 
Binding 
Energy 
(kcal/mol) [1] 
Ka 
(x10
5
M
-1
) 
Ligand binding site 
GFP_s1M 
1 10 12 
-7.03 
-9.78/-0.02 
1.43 
 
2 6 159 
-6.98 
-9.75/-0.02 
1.31 
3 5 69 
-6.97 
-10.08/0.08 
1.29 
4 16 239 
-6.81 
-8.89/-0.07 
0.98 
5 9 231 
-6.79 
-9.23/-0.15 
0.95 
GFP_R 
1 5 71 
-6.85 
-9.25/-0.07 
1.06 
 
 
2 7 14 
-6.62 
-9.1/-0.04 
0.7 
3 1 74 
-6.33 
-7.77/-0.13 
0.11 
4 2 206 
-6.28 
-6.85/-0.06 
0.02 
5 3 235 
-6.23 
-6.84/-0.01 
0.02 
 [1] Estimated binding energy (on top) and two of its components: van der Waals, hydrogen bonding and 
desolvation energy/electrostatic interaction (on bottom). 
 
Looking at the first five docking results for the affinity system GFP/LA-A4C7, we can state 
that this is probably a good ligand for this system since it presents good (very negative) 
estimated energies of binding, and the top ranking clusters are highly populated. The van der 
Waals, hydrogen bonds and desolvation energy are the major contributors to the low 
estimated free energies of binding. However, this information is not enough to decide which 
docking solution to chose.  
Regarding GFP_s1M, the first ranked model (Solution 12) binds to the surface of the β-
barrel structure, near β7 and β8. The solid support binding group is solvent-exposed and the  
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calculated Ka (1.43x105M-1) is in the same order of magnitude as the experimentally 
determined Ka (2.38x105M-1). It was the solution with the lowest estimated free binding 
energy (-7.03kcal/mol). Another remark is that cluster 1 is highly populated (10 solutions 
grouped in the same cluster, within a threshold of 2Å), representing one of the preferential 
docking site at the target protein surface. 
As the location, free binding energies and Ka for the other top-rated solutions are very 
similar, no other solutions were further analyzed in dynamics for this affinity system. 
 
The affinity system GFP_R/LA-A4C7 presents good (very negative) free binding energies. 
Contrary to the results for the affinity system GFP_M/LA-A4C7, the clusters are not as 
populated.  
Solution 71, the top ranked solution for this system binds to the β-barrel structure close to 
the top of the structure, near β10. As seen by the  orientation of the C-terminal residues (to 
the left instead of the right) the docking site is very different from the docking sites found for 
the GFP_M/LA-A4C7 affinity system. The calculated Ka (1.06x105M-1) has the same order of 
magnitude as the experimentally determined Ka (2.38x105M-1). This model was chosen to 
proceed with the modeling task. 
Solution 14, the second best ranked docking solution is located under the protein structure, 
near the loop between β9 and β10, binding to the bottom loops. However the calculated Ka 
(0.72x105M) is already an order of magnitude lower than the experimentally determined Ka 
and was chosen to proceed with the modeling task. 
 
Docking results of the negative control candidate (NA-A7C1) 
The results for the affinity system GFP/NA-A7C1 are summarized in Table 4.5.  
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Table 4.5 - Summary of the docking results for the affinity system GFP/NA-A7C1. 
Target 
protein 
Cluster 
Rank 
Number of 
solutions 
per cluster 
Model 
Solution 
Binding 
Energy 
(kcal/mol) [1] 
Ka 
(x10
5
M
-1
) 
Ligand binding site 
GFP_s1M 
1 2 49 
-6.76 
-8.19/-1.5 
0.9 
 
2 2 248 
-6.47 
-7.99/0.87 
0.55 
3 6 55 
-6.39 
-6.96/-2.18 
0.48 
4 7 215 
-6.01 
-7.41/-1.14 
0.25 
5 1 111 
-5.81 
-7.41/-1 
0.18 
GFP_R 
1 4 142 
-5.82 
-5.62/-2.27 
0.18 
 
2 18 110 
-5.76 
-5.75/-2.11 
0.16 
3 3 236 
-5.73 
-6.44/-2.04 
0.16 
4 1 133 
-5.6 
-7.67/-0.52 
0.13 
5 6 83 
-5.46 
-5/-2.34 
0.10 
[1] Estimated binding energy (on top) and two of its components: van der Waals, hydrogen bonding and 
desolvation energy/electrostatic interaction (on bottom). 
 
Overall, we can see less populated clusters and more positive binding energies than for the 
affinity system GFP/LA-A4C7 (Table 4.4), which would be expected for a negative control.  
 
The first ranked solution for the receptor GFP_s1M (Solution 49) binds on the bottom of the 
barrel, to the loop between the central helix structure and β4, and the chemical group 
necessary to bind to the solid support is unavailable.  
The second top-ranked solution (Solution 248) has a different binding site, located near β7 
and β8. The calculated Ka is an order of magnitude lower (0.55×105M-1) than the experimental 
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value for the GFP/LA-A4C7 system and the resin-binding group is solvent accessible. Therefore, 
this model was chosen to proceed with the modeling studies as a negative control. 
 
Regarding the analysis for the affinity pair GFP_R/NR-A7C1, there are some solutions that 
could not bind to the resin due to the inaccessibility of the resin-binding group to solvent.  
Solution 110 belongs to a very populated cluster and its docking site is located between β8 
and β9. The solid phase-binding group is solvent-exposed and it has a lower Ka=0.16×105M-1, 
one order of magnitude smaller than the calculated Ka values for the lead ligand. This solution 
was chosen as a negative control for this affinity system. 
Solution 236 belongs to the third cluster and its docking parameters are very similar to the 
previous solution, so it was not chosen to proceed with the modeling task. 
 
Some notes have to be in mind when performing a docking protocol. Docking calculations 
can be hampered by a number of reasons: (1) the ligand binds to deep specific pockets of the 
protein structure [16]; (2) the docking protocol does not consider the presence of solvent, but 
a dielectric continuum instead, which can be crucial for hydrogen bonding [71]; (3) attachment 
of the ligand to a solid surface via a spacer arm [16]; (4) ligands with high flexibility; (5) weak 
interactions between the ligand and the protein; (6) large-scale motions of the peptide 
backbone [99]. However, new optimizations and extensions are being developed into existing 
programs to overcome these drawbacks. 
 
4.2.4. Extensive molecular dynamic simulations 
The molecular systems selected to proceed for MD simulations are summarized in Table 
4.6. Before using the GROMOS protocol, the ligands have to be parameterized according to the 
GROMOS96 53a6 force field, in order to assure that the used atom types are compatible with 
the GROMOS force field used in this work. The online server PRODRG was used for this 
purpose. 
The next step was to perform a MD simulation with the complexes summarized in Table 
4.6. Afterwards possible interactions between the molecular complexes were assessed, 
according to the thresholds described in the Methods section. The results regarding possible 
hydrogen bonds and hydrophobic interactions between moieties or atoms of the studied 
ligands and GFP are summarized in Table 4.7. 
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Table 4.6 - Chosen docking poses to proceed for extensive MD for the different affinity pairs analyzed with the GFP 
system. 
Affinity Ligand Homology Model 
Chosen 
Solution 
LA-A4C7 
GFP_s1M 12 
GFP_R 71 
NA-A7C1 
GFP_s1M 248 
GFP_R 110 
 
Table 4.7 - Extensive MD simulation results regarding the interactions between the ligands and GFP. 
Ligand Receptor Solution Main interaction 
Type interaction 
[1] 
Contribution (%) 
LA-A4C7 
GFP_s1M 12 
TYR145:C
ε1
---MOL:CAD Hyd   91,46 
HIS169:C
ε1
---MOL:CAD Hyd   90,17 
HIS148:C
γ
---MOL:CAD Hyd   63,02 
ARG168:N
ε
---MOL:OBI 
 
Hb 28,86 
LYS166:N---MOL:O 
 
Hb 17,43 
TYR151:C
ζ
---MOL:CAA Hyd   10,1 
GFP_R 71 
PHE223:C
γ
---MOL:CAA Hyd  67,29 
TYR143:C
ε1
---MOL:CAD Hyd  29,08 
PHE223:C
δ2
---MOL:CAH Hyd  23,66 
GLN204:N
ε1
---MOL:OBI 
 
Hb 5,77 
PHE223:C
δ1
---MOL:CAD Hyd  4,92 
GLN204:N
ε2
---MOL:O 
 
Hb 2,94 
NA-A7C1 
GFP_s1M 248 
HIS148:C
δ
---MOL:CAC Hyd  26,64 
TYR200:O
η
---MOL:O 
 
Hb 20,23 
TYR200:C
ζ
---MOL:CAC Hyd  17,17 
ASN149:N
γ2
---MOL:OAZ 
 
Hb 8,73 
TYR200:O
η
---MOL:OBA 
 
Hb 5,79 
ASN149:N---MOL:O 
 
Hb 5,52 
GFP_R 110 
TYR182:O
η
---MOL:OAZ 
 
Hb 3,84 
SER99:O
γ
---MOL:OAT 
 
Hb 2,65 
ASN164:O
γ1
---MOL:NAW 
 
Hb 0,96 
Note: GFP atoms are identified according to the recommended atom identifiers following the 1969 IUPAC-IUB 
guidelines (consult [100]). 
[1] The interactions are classified as hydrophobic (Hyd) or hydrogen bond (Hb). 
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Table 4.7 shows many relevant interactions (above 10% of the simulation time) between 
GFP and LA-A4C7. Due to its hydrophobic character the hydrophobic interactions are 
predominant. Some of the interactions between LA-A4C7 Solution 12 and GFP_s1M are shown 
in Figure 4.8. The most relevant hydrophobic interactions were found between a heavy atom 
of the pyrene ring (CAD) and the benzene ring of the TYR145 side chain (Figure 4.8a). By its 
stable distance profile, we can observe that the ligand has found a stable docking pose. Other 
hydrophobic interactions (e.g. between the ligand and HIS169, HIS148 or TYR151) contribute 
for the binding of the ligand to this docking pose. On the other hand hydrogen bonding also 
contributes for the ligand binding (e.g. between ARG168 side chain and the ligand (OBI) at the 
end of the simulation - Figure 4.8b). 
 
 
Figure 4.8 - Monitoring the distance between GFP/LA-A4C7 Solution 12 during the MD simulation trajectory (a) 
between TYR145:C
ε1
 and LA-A4C7:CAD, and (b) between ARG168:N
ε
 and LA-A4C7:OBI. (c) Ligand LA-A4C7 and atom 
types involved in the main interactions in Table 4.7. 
Although some relevant interactions were found between Solution 71 and GFP_R, a larger 
number of relevant interactions were found between Solution 12 and GFP_s1M. This is in 
agreement with the docking results described before for both models: the estimated binding 
energy of Solution 71 (-6.87kcal/mol) is more positive than the estimated binding energy of 
Solution 12 (-7.03kcal/mol). With this information we can conclude that the docking pose of 
Solution 12 (between β7 and β8) is a more probable binding site location than the docking 
pose of Solution 71. On the other hand, and according to the results found for Solution 71 in 
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terms of estimated binding energy, Ka and relevant interactions, this solution should not be 
discarded as an alternative binding site. 
 
Regarding ligand NA-A7C1 Solution 110, no relevant interactions were found with GFP. The 
interactions shown in Table 4.7 occur at the beginning of the simulation, after which the ligand 
distances itself from the protein surface.  
On the other hand for the NA-A7C1/GFP_s1M Solution 248 system some relevant 
interactions were found, mostly hydrophobic. The distance profiles for these interactions are 
shown in Figure 4.9. However, contrary of what was observed for LA-A4C7, the interactions 
happen only at the beginning of the simulation (Figure 4.9a), occur in short periods (Figure 
4.9b) or occur only once in the middle of the simulation (Figure 4.9c).  
 
Figure 4.9 – Monitoring the distance between GFP/NA-A7C1 Model 248 during the MD simulation, (a) between 
HIS148:C
δ
 and NA-A7C1:CAC, (b) between TYR200:O
η
 and NA-A7C1:O, and (c) between TYR200:C
ζ
 and NA-
A7C1:CAC. (d) Ligand NA-A7C1 and atom types involved in the main interactions in Table 4.7. 
 
According to the modeling results and comparing them with the results found for the LA-
A4C7/GFP affinity system, NA-A7C1 acts according to a poor ligand for this system and has a 
decreased probability of displaying affinity towards GFP.   
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In reality NA-A7C1 was used as the lead ligand for RK-GFP. This will be considered during 
the analysis of the results for this affinity pair system in Section 4.4. 
 
 
4.3. In silico 2nd generation library of ligands for binding of GFP 
The goal of this section was to create a second generation of ligands with affinity towards 
GFP which presented better theoretical estimated binding energy and affinity constant than 
ligand LA-A4C7. For this purpose two strategies were followed, which will be described below.  
 
4.3.1. Docking-based second generation library 
The first strategy was based on a characterization of the docking pose of solution 71 of the 
GFP_R/LA-A4C7 pair. This docking solution was characterized by an estimated binding energy 
of -6.87kcal/mol and an affinity constant of 1.06×105M-1. Its location is shown in Figure 4.10a. 
 
Figure 4.10 - Solution 71: lowest estimated free binding energy docking hypothesis for the affinity system 
GFP_R/LA-A4C7. a) Location of the ligand (colored by atom type) on the surface of the GFP_R structure (in green). 
b) Close-up to the docking location in a). An hydrophobic patch is shown by surface display and key amino acids are 
shown in sticks. 
As shown in Figure 4.10b the pyrene ring of LA-A4C7 establishes hydrophobic interactions 
with a hydrophobic patch located at the surface of GFP formed by Leu141, Tyr143, Tyr145 and 
His148. The benzene ring of LA-A4C7 establishes hydrophobic interactions with these residues. 
However, there is a lack of chemical groups that could interact via hydrogen bonds with 
surrounding residues. There are some residues in a close distance (namely Asn146, Asn144 and 
Glu142, shown in Figure 4.10b) that could interact via hydrogen bonds with nearby hydroxyl, 
carboxyl or other hydrogen-bonding capable groups from the ligand. 
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Based on the need of hydrophobic and polar groups, a library of amine and carboxylic 
compounds was constructed (Table 4.8).  
 
4.3.2. Nanobodies-based second generation library 
The second strategy was based on an extensive PDB search for existing structures of 
molecules binding to GFP. Until date, the only available structures were published by 
Kirchhofer and colleagues [101]. Their work was regarding two small proteins (named 
nanobodies) that could bind to GFP and affect its fluorescence, increasing it (Enhancer) or 
decreasing it (Minimizer). Three binding sites where chosen (shown in Figure 4.11), based on 
their influence in both binding partners (Minimizer and Enhancer) and the proximity between 
residues (e.g. consecutive triads).  
 
 
Figure 4.11 – Three amino acid triads (a, b and c) that are part of binding sites described in [101] for the Enhancer 
(E) and the Minimizer (M) to GFP. Below each binding site, the key residues are represented in stick display, as well 
as the distances between the chemical groups involved in hydrogen bonding (in Å). 
 
The key residues involved are glutamic acids, tyrosines and arginines for both examples 
(Minimizer and Enhancer). The second generation Ugi library (Table 4.8) was based on the side 
chains of these amino acids, resulting in a selection of more hydrophilic compounds than the 
previous library. 
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Table 4.8 - Library of 2
nd
 generation of Ugi-based ligands resulting from the docking-based (A1, A2, A3, A4, A5, C1 and C2) and the nanobodies-based (A6, A7, A8, C3, C4, C5, C6, C7) strategies. 
 A1 
2-amino-1H-
benzimidazole-
5-carboxylic 
acid 
 
 
 
 
A2 
6-amino-naphtol
 
 
 
 
A3 
4-biphenyl-3’-
amino-acetic 
acid
 
A4 
1-pyrene 
methylamine 
hydrochloride 
 
A5 
3-(1,3-benzodioxol 
-5-yl)-4-phenyl-1-
butanamine
 
A6 
Aminoacetic 
acid 
 
 
A7 
4-
aminobutyric 
acid 
 
A8 
4-
hydroxybenzylamine 
 
 
C1 
2,3-
dioxoindoline-7-
carboxylic acid 
 
C2 
4,5-dihydroxy-9,10-
dioxo-9,10-dihydro-2-
anthracenecarboxylic 
acid 
 
C3 
Malonic acid 
 
C4 
β-glutamic 
acid 
 
C5 
3,4-dihydroxyhydro 
cinnamic acid 
 
C6 
4-Acetoxy 
hydrocinnamic 
acid 
 
C7 
3-Guanidino 
propionic acid 
 
 
A
m
in
es
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The next step was to perform a blind docking to GFP and chose the ligands that presented 
better estimated binding energy and affinity constant when compared to LA-A4C7.  
 
 
To combine the characteristics of each library, both libraries were combined. Therefore, a 
total of 56 Ugi-based ligands (8amines×7carboxylic acids) were tested by a blind docking 
search onto the GFP receptor. 
 
4.3.3. Affinity pair docking  
The results of the blind docking with the 56 ligands from the 2nd generation library are 
summarized below.  
45 ligands out of 56 (80.35%) had better estimated binding energy and Ka than LA-A4C7 
(solution 71, -6.87kcal/mol and 0.106μM-1, respectively). The first (A4C2) and the last (A7C7) 
classified of the 56 ligands are shown in Table 4.9. The best scored ligand displays a very 
negative binding energy and an affinity constant four orders of magnitude higher than LA-
A4C7, being a very promising ligand. 
 
Table 4.9 - First (A4C8) and last (A8C14) classified ligands of the 2nd generation library. 
Ligand 
Cluster 1 
Docking 
solution 
Binding energy 
(kcal/mol) 
Population/cluster 
Ka  
(μM-1) 
A4C2 6 -13.47 2 7463.24 
A7C7 107 -7.15 1 0.18 
 
Figure 4.12 summarizes the frequency of each amine and carboxylic compounds that are 
part of the 56 best-rated ligands. The amines that were more common were A2, A3, A4 and 
A5, all belonging to the first library. The carboxylic acids also corroborated this assumption, as 
the most common compounds belonged to the first hydrophobic library (C2) and the second 
was chosen to mimic the tyrosine side-chain in the second library (C5). Both corroborated the 
need of a hydrophobic moiety to contribute for the binding to GFP, as it was observed by the 
hydrophobic ligand LA-A4C7.  
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Figure 4.12 – Number of ligands which contain each amine or carboxylic acid summarized in Table 4.8  
Figure 4.13 can give an idea of the range of binding energy values of the 56 analyzed 
ligands. Ligand A4C2, the best-rated ligand (see Table 4.9), is represented in green (very 
negative binding energy value) and ligand A7C7 is represented in red. These results are a 
mirror of the results shown in Figure 4.12, where more abundant compounds belong to ligands 
with better binding energy (e.g. A4 and C2). 
 
 
Figure 4.13 - Schematic representation of a 96-well microplate colored by the value of each ligand’s estimated 
energy of binding to GFP (green>yellow>orange>red). In light grey: ligands with binding energy values more positive 
than LA-A4C7 M71.  
 
All 56 initial ligand can be synthesized on a solid support and the experimental results 
compared to the blind docking results. One should notice that the results can vary due to the 
molecular docking limitations:  (1) the docking is done between one ligand and one receptor, 
and (2) the ligand is solvent-free and not bound to a solid support.  
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4.4. In silico study of affinity ligands for the purification of RK-
GFP 
4.4.1. Homology modeling  
The nucleotide and amino acid sequences corresponding to the RK-GFP used in this work 
are shown in Figure 3.1b, in the Methods section. The difference between GFP and RK-GFP 
protein sequence is a set of eighteen amino acids fused to the N-terminal: “RKRKRK-
PPPDDDDKG-TGS”. 
 One of the main goals of the RK-GFP modeling task is to understand the structural 
implications of the presence of an extra N-terminal peptide, and if it can have a deleterious 
effect on the GFP structure due to intramolecular interactions. It has been reported that 
insertions into the GFP sequence can alter GFP fluorescence [102] or stability [103]. However 
many crystallographic structures have been deposited in the PDB regarding GFP-fusion 
proteins and the characteristic β-sheet barrel of GFP is conserved (e.g. GFP-fusion myosin, PDB 
ID code 4ANJ; calmudolin, 3EVR; cytochrome b562, 3U8P). 
 
The first step according to the homology modeling protocol is to find suitable templates. 
Homologous structures with the query sequence “RKRKRK-PPPDDDDKG-TGS” were not found 
in a preliminary NCBI BLASTp search. 
Using the RK-GFP protein sequence as query, the same templates as for GFP (see Table 4.1) 
are retrieved and the same set of homology modeling software were used. The resulting 
models were evaluated based on the same scores as before and the homology modeling 
evaluation results are shown in Table 4.10. 
 
Selected homology models for RK-GFP 
Using the protein sequence of RK-GFP as a query in SWISS-MODEL did not return a model 
that included the N-terminal tag residues. The rigid body assembly method used by SWISS-
MODEL [49] is not adequate to model sequences that do not have an associated template or 
when the alignment contains large gaps. 
According to the evaluation results present in Table 4.10, two of the obtained homology 
models for RK-GFP were chosen to proceed with the modeling task: homology model obtained 
by Modeller (RK-GFP_s1M) and by Rosetta (RK-GFP_R) (Figure 4.14). 
 
64 
 
 
 
 
Figure 4.14 - Best homology models obtained for RK-GFP using (a) Modeller, and (b) Rosetta. The backbone 
structure is colored in gradient from blue (at N-terminal) to red (at C-terminal) of the structure. Two helix structures 
are highlighted with yellow and blue arrows. Displayed using cartoon representation in PyMol. 
 
As shown in Figure 4.14, the two models have similar structure and packing and none have 
an associated secondary structure for the tag residues (colored in dark blue). The main 
structural differences are: (1) the orientation of the C-terminal residues and corresponding 
secondary structure (in red); (2) the orientation of the tag residues in N-terminal (in dark blue); 
(3) the length of the helix structure highlighted by the dark blue arrow; (4) the subtle 
difference in orientation and length of some of the loops between the beta-sheets; and (5) the 
presence of a helix structure (yellow-colored loop) in the RK-GFP_R model but not  in the 
GFP_s1M. 
As described before, the interest in proceeding with the two models in parallel is to do a 
systematic search for structural inconsistencies and to avoid any computational bias. 
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Table 4.10 - Summary of the comparative homology modeling evaluation for the homology models obtained for the RK-GFP amin oacid sequence. The best result for each score is highlighted 
in green. 
 
Template 
 
 
GROMOS 
[4] 
RMSD 
(Å) 
SOLVX 
  
QMEAN (z-score) 
 
Identity 
[2] 
ANOLEA [3] 
VERIFY3D 
[5] 
Overall 
Score 
Cβ 
interaction 
All-atom 
interaction 
Solvatation Torsion 
Secondary 
structure 
agreement 
Solvent 
accessibility 
agreement 
SWISS- 
MODEL [1] 
- - - - - - - - - - - - - - 
Modeller 1QYO 98.31% 89.53% 53.88% 1.024 -139.3 
0.78% 
5.81% 
0.4 -1.07 -1.46 0.45 -1.51 0.8 1.13 
Rosetta 2WUR [6] 97.90% 94.96% 69.38% 0.902 -139.4 
3.10% 
4.56% 
-0.64 -1.24 -1.51 -0.28 -0.68 0.66 -0.42 
I-TASSER 
1B9C, 
3NED, 
1KYP, 
3U8P, 
2VZX, 
3CGL [7] 
[8] 45.35% 27.48% 
6.2 
[9] 
-143.3 
1.94% 
0.78% 
-1.43 -1.17 -2.14 0.63 -4.01 -0.89 0.57 
[1] SWISS-MODEL could not model the RK-GFP sequence due to the tag residues having no alignment correspondence. 
[2] The value corresponds to the identity when aligned to the GFP sequence. 
[3] Percentage of residues that were scored positively (>0) by the ANOLEA score. 
[4] Percentage of residues that were scored positively (>0) by the GROMOS score. 
[5] Percentage of residues that were scored as bad (0-1.1; first line) and very bad (<0; second line) by the VERIFY3D score. 
[6] Protocol does not allow choosing the template, which is chosen based on the multi pair-wise alignment preformed by HHpred.  
[7] Most of the selected templates were also chosen for the GFP homology modeling_ . 
[9] RMSD value calculated by the I-TASSER webserver. 
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4.4.2. Structural relaxation of homology models 
MD simulations of the models found for RK-GFP (RK-GFP_s1M and RKGFP_R) were carried 
out. Analyses of the obtained results are summarized in Figure 4.15 for the RK-GFP_s1M and 
Figure 4.16 for the RK-GFP_R.  
 
By Figure 4.15a, one can see that the predicted C-terminal associated -helix structure of 
RK-GFP_s1M vanished after 10ns of simulation. This unfolded structure was also shown by the 
GFP_s1M after structural dynamical relaxation (see Figure 4.5). The conserved β-barrel 
structure of the GFP protein [75] undergoes some point flexibility compared to the tag’s 
flexibility, as represented by the variation of the RMSF values in Figure 4.15b, in blue. The 
profile of RMSD has higher values than the ones for the GFP_s1M model (Figure 4.15b, in red) 
and this is a direct result of the high flexibility of the N-terminal tag residues (Figure 4.15c, in 
blue, and Figure 4.15d, in red), which deviate from the reported 0.5-2.0Å for proteins in 
equilibrium [78]. Although the unfolding of the C-terminal residues resulted in high RMSF 
values, higher values of RMSF are obtained for the flexible N-terminal tag residues. 
 
 
Figure 4.15 - Results obtained after the first MD simulation for the RK-GFP_s1M. a) Superimposition of the model 
obtained by Modeller before MD simulation (in blue) and after MD simulation (in green). b) Variation of the RMSD 
values along the MD simulation trajectory. c) RMSF values per residue. d) B-factor representation of structure 
flexibility colored in gradient. Blue represents residues with less flexibility and red represents residues with more 
flexibility average over the entire trajectory. 
 
The RK-GFP_R had a very similar behavior to the one predicted by Modeller (Figure 4.16a). 
The N-terminal residues remain with no associated secondary structure and solvent-exposed. 
The helix-structure highlighted by the yellow arrow in Figure 4.14 is lost and the long helix-
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structure in the C-terminal residues is reduced, as shown in Figure 4.16a2. The RMSD values 
tend to converge among the two models (RK-GFP_R and RK-GFP_s1M) despite the RMSF 
values for the N-terminal residues are lower for RK-GFP_R (Figure 4.16c). This can result from 
the close proximity between the N- and C-terminal residues as shown in Figure 4.16a1. 
 
 
Figure 4.16 - Results obtained after the first MD simulation for the RK-GFP_R. a) Superimposition of the model 
obtained by Rosetta before MD simulation (in blue) and after MD simulation (in green). b) Variation of the RMSD 
values along the MD simulation trajectory. c) RMSF values per residue. d) B-factor representation of the structure 
flexibility colored in gradient. Blue represents residues with less flexibility and red represents residues with more 
flexibility average over the entire trajectory. 
 
4.4.3. Automated molecular docking 
The homology models obtained for RK-GFP were used as receptors to dock the affinity 
ligands LR-A7C1 (lead ligand) and NR-A5C2 (worst ligand). The coordinates of the LR-A7C2 
(Figure 4.17a) and NR-A5C2(Figure 4.17b) were set up based on previous experimental solid 
phase affinity results of the complex [47]. The experimentally determined affinity constant for 
the affinity pair RK-GFP/LR-A7C2 was Ka= 2.45×105M-1. 
 
Figure 4.17 - Molecular structures of the solid phase screened ligands for RK-GFP system. a) Lead ligand with the 
best affinity for the RK-GFP and b) Negative control ligand with the worst affinity for RK-GFP system. The chemical 
group used to immobilize the ligand into the solid support is highlighted in red. 
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After assigning the correct atomic parameterization and molecular topology to the ligands, 
they were docked onto the receptor using the Lamarckian genetic algorithm as implemented 
in the Autodock software package.  
 
Docking results of the lead candidate (LR-A7C1) 
The results for the affinity system RK-GFP/LR-A7C1 are summarized in Table 4.11. 
 
Table 4.11 - Summary of the docking results for the affinity system RK-GFP/LR-A4C1. 
Target 
protein 
Cluster 
Rank 
Number of 
solutions 
per cluster 
Model 
Solution 
Binding 
Energy 
(kcal/mol) 
[1] 
Ka 
(x10
5
M
-1
) 
Ligand binding site 
RK-
GFP_s1M 
1 19 9 
-7.69 
-7.64/-2.71 
4.33 
 
2 4 148 
-7.13 
-5.97/-3.34 
1.06 
3 7 183 
-6.92 
-5.76/-2.75 
1.00 
4 6 66 
-6.81 
-6.7/-2.29 
0.98 
5 2 211 
-6.40 
-6.27/-2.14 
0.49 
RK-GFP_R 
1 2 170 
-7.18 
-5.71/3.7 
1.55 
 
2 6 163 
-7.07 
-6.00/-3.48 
1.50 
3 7 160 
-6.91 
-7.20/-2.28 
1.17 
4 4 72 
-6.60 
-6.38/-2.63 
0.69 
5 6 230 
-6.56 
-5.77/-3.30 
0.65 
[1] Estimated binding energy (on top) and two of its components: van der Waals, hydrogen bonding and 
desolvation energy/electrostatic interaction (on bottom). 
 
Overall, top ranking hits achieved very good energies of binding and correspondent docking 
clusters are highly populated, especially for the RK-GFP_s1M receptor. Interestingly, all five 
top ranking poses are located near the N-terminal tag residues.  
The first ranked model for the RK-GFP_s1M receptor (Solution 9) might interact via 
hydrogen-bonds with tag residues (R3, K4 and K6) as with other residues (G246 and N216). The 
anchoring chemical group used for immobilization is solvent-exposed which fulfills one of the 
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criteria stated before. Moreover, the predicted Ka=4.33x105M-1 is in the same order of 
magnitude as the experimentally determined Ka=2.45x105M-1. Solution 9 was the solution with 
the lowest estimated free binding energy (-7.69kcal/mol). On the other hand, cluster 1 is highly 
populated (19 solutions).  
Solution 148 is the second top ranking solution for this system. This solution has a very 
similar binding site to the previous model, with a different orientation. In this solution, the 
ligand is located at a distance consistent with the formation of hydrogen bond interactions 
with R1, K2 and R5. Solution 148 is an interesting model to investigate further since observed 
interactions occur to different N-terminal tag residues than Solution 9. On the other hand, all 
other criteria are fulfilled. 
No more solutions listed for the RK-GFP_s1M receptor were further analyzed as the 
corresponding clusters were not as populated and the binding location is very similar to the 
previous models. 
 
The affinity system RK-GFP_R/LR-A7C1 presents good binding energies, although the 
clusters are not as populated as for the previous homology model. This receptor presents two 
main binding sites locations. Solution 160, from Cluster 3 in the ranking (in green) was 
discarded due to higher value of estimated energy of binding. 
The binding site of Solution 170 in Cluster 1 allows hydrogen-bond interactions with N-
terminal tag residues, namely R1, K4 and R5. The predicted Ka=1.06x105M-1 has the same 
order of magnitude as the experimentally determined Ka and the anchoring chemical group 
necessary to bind to the resin is solvent-exposed. This model was chosen to proceed with 
molecular dynamics simulations. 
The next top ranked model, Solution 163, also satisfies the given assumptions about the 
support-binding group, Ka and preferential binding to N-terminal residues. This is the docking 
solution which includes a higher number of possible interactions with different tag residues 
(R1, R3, K4 and R5). 
 
Docking results of the negative control candidate (NR-A5C2) 
The results for the affinity pair RK-GFP_s1M/NR-A5C2 are summarized in Table 4.12. 
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Table 4.12 - Summary of the docking results for the affinity system RK-GFP/NR-A5C2. 
Target 
protein 
Cluster 
Rank 
Number of 
solutions 
per cluster 
Model 
Solution 
Binding Energy 
(kcal/mol) [1] 
Ka 
(x10
5
M
-1
) 
Ligand binding site 
RK-GFP_s1M 
1 2 238 
-7.96 
-9.61/0.50 
6.80 
 
2 14 164 -6.73 0.86 
3 1 160 
-6.68 
-9.5/-0.11 
0.78 
4 4 27 
-6.67 
-8.38/-0.24 
0.77 
8 1 89 
-6.38 
-8.97/0.05 
0.47 
RK-GFP_R 
1 1 173 
-8.18 
-10.28/-0.46 
9.90 
 
2 1 240 
-7.13 
-10.28/-0.46 
1.67 
3 1 227 
-6.89 
-9.10/-0.51 
1.13 
5 1 184 
-6.47 
-7.12/-0.42 
0.55 
8 4 243 
-6.29 
-7.89/-0.35 
0.41 
[1] Estimated binding energy (on top) and two of its components: van der Waals, hydrogen bonding and 
desolvation energy/electrostatic interaction (on bottom). 
 
Contrary to what was expected for a negative control ligand, docking solution revealed very 
negative estimated free energies of binding. However the docking sites are much more 
disperse and most docking solutions are not located near the tag residues.  
 
The first ranked solution for the receptor RK-GFP_s1M (Solution 238) binds underneath the 
structure, to the loop between the central helix structure and β4, leaving the chemical group 
necessary to bind to resin unavailable. The second top-ranked model (Solution 164) has a 
similar binding site to the previous hit. The calculated Ka is an order of magnitude lower 
(0.8×105M-1) than the experimental one, but in this case the resin-binding group is solvent 
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accessible. These models were not chosen to proceed with the modeling task due to the non-
relevant binding location. 
Solution 160 of cluster 3 was chosen to proceed as there is a possible hydrogen bond 
interaction between the ligand and K6 and the resin-binding group is solvent-accessible. It has 
a predicted Ka= 0.8×105M-1, one order of magnitude lower than the experimentally 
determined Ka for LR-A4C7. 
The next four models do not have a binding site near the tag residues, so they were not 
further analyzed. 
Solution 89, the eighth model for the RK-GFP_s1M receptor represents a promising docking 
solution. The resin-binding group is solvent-accessible and there is a possible hydrogen bond 
interaction with K6 and H95. It has a low Ka=0.4×105M-1 compared to the experimentally 
determined Ka for LR-A4C7. This model was chosen to proceed for MD simulations, as a 
negative control. 
 
Regarding the analysis for the affinity pair RK-GFP_R/NR-A5C2 the clusters are not as 
populated as for the pair RK-GFP_s1M/NR-A5C2, but there are docking results that display 
good estimated free energy of binding. Most docking solutions do not bind near the N-
terminal tag residues, while others could not binding to the solid support. The models from 
cluster 5 (in orange) and cluster 8 (in purple) will be further analyzed and were chosen to 
precede with the MD simulations. 
Solution 184 is the only solution of cluster 5 and its docking site is located near the N-
terminal tag residues establishing a hydrogen bond interaction with R5. The resin-binding 
group is solvent-exposed and it has a lower Ka=0.5×105M-1, one order of magnitude smaller 
than the calculated Ka values for the lead ligand.  
Solution 243 belongs to eighth ranked cluster, but it was analyzed because of its binding 
location, at interacting distance through hydrogen bonds with R3 and D252 (located near the 
C-terminal). The estimated free energy of binding and the calculated Ka are similar to the last 
analyzed solution. 
 
4.4.4. Extensive Molecular Dynamic Simulations  
The docking solutions chosen to proceed with the MD simulations are summarized in Table 
4.13. 
 
72 
 
Table 4.13 - Chosen docking poses to proceed for extensive MD for the different affinity pairs analyzed with the RK-
GFP system. 
Affinity Ligand 
Homology 
Model 
Chosen 
Solution 
LR-A7C1 
RK-GFP_s1M 
9 
148 
RK-GFP_R 
170 
163 
NR-A5C2 
RK-GFP_s1M 
160 
89 
RK-GFP_R 
184 
243 
 
At this stage we were looking for significant interactions (>10% of the simulation time) 
between the best ligand LR-A7C1 and RK-GFP and no significant interactions between the 
negative control ligand NR-A5C2 and RK-GFP. Mostly hydrogen bond interactions were studied 
as the tag residues have a hydrophilic character in Nature. The results are summarized in Table 
4.14 and the atoms of the ligands involved in the interactions analyzed are shown in Figure 
4.18. 
 
 
Figure 4.18 - Ligands (a) LR-A7C1 and (b) NR-A5C2 and the atoms involved in the studied interactions in Table 4.14. 
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Table 4.14 - Extensive MD simulation results regarding the interactions between the ligands and RK-GFP. 
Ligand Receptor 
Mode
l 
Main interaction 
Type interaction 
[1] 
Contribution (%) 
LR-A7C1 
RK-GFP_s1M 
9 
LYS2:N---MOL:OAZ 
 
Hb 6.87 
LYS2:N
ζ
---MOL:OBA 
 
Hb 3.3 
LYS6:N
ζ
---MOL:OBA 
 
Hb 0.12 
148 
LYS2:N---MOL:OAZ 
 
Hb 22.14 
LYS2:N---MOL:OBA 
 
Hb 21.6 
LYS2:N
ζ
---MOL:O 
 
Hb 8.83 
LYS2:N---MOL:OBC 
 
Hb 5.11 
LYS2:N---MOL:OBC 
 
Hb 5.11 
ARG1:N
ε
---MOL:OBB 
 
Hb 1.57 
ARG1:N
ε
---MOL:OBC 
 
Hb 1.48 
ARG1:N
η2
---MOL:OBC 
 
Hb 0.89 
RK-GFP_R 
170 
LYS4:N
ζ
---MOL:O 
 
Hb 1.81 
ARG1:N---MOL:OAT 
 
Hb 1.4 
163 
LYS4:N---MOL:OAT 
 
Hb 6.54 
ARG5:N---MOL:OBB 
 
Hb 0.97 
ARG1:N
ε
---MOL:OAT 
 
Hb 0.92 
NR-A5C2 
RK-GFP_s1M 
160 No detected interaction 
89 
LYS6:N
ζ
---MOL:OAX 
 
Hb 3.85 
LYS6:N
ζ
---MOL:O 
 
Hb 2.65 
RK-GFP_R 
184 No detected interaction 
243 ARG3:N
ε
---MOL:OAX 
 
Hb 5.86 
Note: GFP atoms are identified according to the recommended atom identifiers following the 1969 IUPAC-IUB 
guidelines (adapted from [100]). 
[1] The interactions are classified as hydrophobic (Hyd) or hydrogen bond (Hb). 
 
 
As expected the docking solutions corresponding to NR-A5C2 had fewer interactions with 
the protein and did not give any hits on significant hydrogen bond interactions. NR-A5C2 has 
lower experimental Ka and that was supported by the MD results. The longest interactions 
found represent less than 6% of the simulation time and occur mostly at the beginning of the 
simulation (near the initial docking pose). 
 
A coherent behavior was observed for the LR-A7C1/RK-GFP system. Most of the models 
studied did not present significant interactions between RK-GFP and the ligand, breaking up 
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this complex after a few nanoseconds. In addition to presenting the higher number of 
interactions with RK-GFP Solution 148 showed an interesting feature (Figure 4.19a).  
This interaction is a hydrogen bond between the second lysine residue of the tag and two 
adjacent oxygen atoms of ligand LR-A7C1 (in Figure 4.19b). Both oxygen atoms contributed for 
a hydrogen interaction that lasts 42.89% of the total simulation time. This is an on/off 
interaction: when LYS2 is not interacting with oxygen atom, it is able to interact with the 
adjacent oxygen atom. Although the ligand in some part of the simulation is detached from the 
protein, the interaction is strong enough to occur again at the end of the simulation time 
between both oxygen atoms.  
The same functional group is found on the other side of the molecule and it would be 
predictable that there would be an interaction between these atoms and the protein. However 
this was not found during the MD conformational search.   
 
 
Figure 4.19 - (a) Variation of the distance between LYS2:N and LR-A7C1:OAZ and between LYS2:N and LR-A7C1:OBA 
during the second MD trajectory. Results regarding RK-GFP_s1M and Solution 148. Notes: BB- backbone; SC – side-
chain. (b) Ligand LR-A7C1. The atoms OAZ and OBA are circled in red. 
 
 
4.5. Conclusions and Future Directions 
The results for the systems GFP and RK-GFP and their correspondent lead and negative 
control ligands were quite promising to explain the experimental results previously obtained in 
[47].  
Many relevant hydrophobic interactions were found between GFP and LA-A4C7, the best 
ligand, over 90% of the MD simulation that can explain the experimental results. The 
interactions between GFP and NA-A7C1 were less predominant during the MD simulation, 
which is coherent with the decreased affinity towards GFP [47]. 
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On the other hand, for the RK-GFP receptor only one of the docking solutions was in 
agreement with the experimental results [47], with an interaction over 40% of the simulation 
time. All other models had interactions that were present less than 10% of the simulation, 
including docking of the best ligand, which creates doubts about some key aspects.  
First, is the sampling efficient enough? Choosing more docking poses to study by extensive 
MD would give a higher probability of finding more than one accordant solution. However it is 
computationally demanding. 
Second, would a larger sampling influence the negative results that were obtained for the 
negative control ligand? However doing a significant sampling is very time consuming and data 
extensive.  
Third, one of the criteria to choose the docking poses was that the ligand would bind near 
the tag residues in RK-GFP. Although most of the best-scored clusters were located near the 
RK-tag, this location can provide few stabilizing interactions. The results found for the GFP/NA-
A7C1 system in section 4.2.4 confirm this hypothesis – there can be other alternative binding 
sites for ligand LR/NA-A7C1. When a different docking pose was chosen (e.g. Solution 248) 
some relevant interactions were found to occur between the ligand and the GFP surface. 
However when comparing the docking results for two examples (e.g. GFP/NA-A7C1 M248 and 
RK-GFP/LA-A7C1 M148) the first model has a more positive binding energy and a lower Ka 
value, which supports the selectivity of the ligand NA/LA-A7C1 to the tag residues.  
 
Other important remarks have to be done about this theoretical study for both for GFP and 
RK-GFP systems. 
We studied a simplification of the system, in terms of protein, ligand and salt 
concentrations. MD methodological issues are related with solution conditions, the accuracy of 
the force field and sufficient sampling [79]. 
On the other hand the ligand is in its free form (soluble in solution), while experimentally it 
is tethered to a chromatographic surface. Although some measures were taken to take this 
into account, its immobilization affects the ligands’ mobility and conformational space 
available for protein interaction, as described in Freed et al [79].  
Therefore, this study can only be used as a first approach to explain the experimental 
results previously obtained [47]. 
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Other interesting studies could be done. One would include using the same systems while 
simulating the elution conditions used by Pina [47] or with different elution conditions (pH, 
ionic strength). 
 
Regarding the design of a 2nd generation library towards GFP, all 56 initial ligands can be 
synthesized on agarose beads or other solid supports and the experimental results can be 
compared to the theoretical results. One should notice that the results can vary due to the 
docking limitations. Furthermore, the binding and elution conditions can be optimized for the 
new affinity system.  
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5.1. Purification methodologies for GFP 
The GFP gene can be manipulated using standard molecular biology tools and it is widely 
used to create fusion constructs and labelled-proteins [104], to monitor protein expression 
[47], study protein stability [105], folding/unfolding phenomena [106], overexpression [107] 
and many other applications. However, few purification techniques for GFP-fusion proteins 
have been described. 
GFP recovery is mostly based on IMAC [108,109] or Q-Sepharose columns [110,111]. An 
organic and chromatographic extraction has been described [112], as well as Ni-NTA-
functionalized magnetic particles for the purification of His-tagged GFP [113]. The His-tagged 
version of nanobodies described in [101] was used to bind GFP to a Ni-NTA column. Fukuda et 
al have described a four step purification protocol that relies on differential precipitation, two 
gel filtrations and ion-exchange chromatography [114]. Commercially, anti-GFP antibodies-
based affinity purifications are available. Milteniyi offers superparamagnetic microbeads 
(μMACS® technology) and Chromotek has monovalent matrices (agarose beads, magnetic 
particles or 96-multiwell plates) functionalized with GFP-TRAP® for the purification of GFP and 
GFP-fusion proteins. 
Therefore there is a need for a rapid and efficient purification method for GFP. In [47] a 
novel affinity ligand for GFP has been tethered to agarose beads and allowed the recovery of a 
very pure GFP fraction. 
 
 
5.2. Purification methodologies for tagged-proteins 
Fusing an affinity tag to the target protein allows its purification, with high yields and 
purity. Nowadays many options are available according to the final application. A summary of 
some available tags and their correspondent affinity ligand is available in Table 6.1 
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Table 6.1 - Examples of currently used tags and specific affinity ligands in protein purification strategies. Adapted 
from [17,20]. 
Tag 
Size 
(aa) 
Ligand Other properties Examples 
His-tag 5-15 
Ni
2+
-nitrilotriacetic acid, Co
2+
-
carboxymethylaspartate 
- [107] 
FLAG 8 Anti-FLAG monoclonal antibody - [115] 
Strep-tag 8 
Strep-tactin (modified 
streptavidin) 
- [116] 
HA-tag 9 Co
2+
- carboxymethylaspartate - [117] 
myc-tag 10 Monoclonal antibody - [117] 
S-tag 15 S-fragment of RNaseA - [118] 
Elastin-like peptides 18-320 Non-chromatographic 
Response to ionic 
strength and 
temperature 
[119] 
Chitin-binding 
domain 
52 Chitin - [120] 
Gluthathione-S-
tranferase 
201 Glutathione 
Increase protein 
solubility 
[121] 
Maltose binding 
protein 
396 Cross-linked amylose 
Increase protein 
solubility 
[121] 
 
There is a constant search for novel affinity tags that allow high purity and recovery of the 
target protein. In [47] the properties of novel proteic tags and their correspondent affinity 
ligand have been studied and allowed the recovery of a pure tagged-GFP fraction. In this work 
we will study the application of “RKRKRK” as affinity tag. 
 
 
5.3. Objective 
The small size and large surface area to volume ratio of magnetic nanoparticles in addition 
to their superparamagnetic properties make them highly attractive as solid supports for 
adsorptive separations [2]. Many proteins have been purified using magnetic techniques [1], 
where the affinity is conferred by the coating [7,122], metal chelants at the surface [113], 
affinity ligands (examples are shown in Table 1.1), or other molecules – see [11]. 
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In this chapter we described the use of a new solid support for the purification of GFP and 
tagged-GFP. For this purpose, we accomplished two goals: (1) we have produced GFP and RK-
GFP in E. coli, and (2) we have functionalized magnetic nanoparticles with the most promising 
affinity ligands described in [47] and shown in Table 2.1 for the purification of GFP and RK-GFP. 
 
 
5.4. Production of GFP and RK-GFP in E. coli  
5.4.1. Fragment DNA design and DNA purification 
The DNA fragments that were cloned into the pET-21c plasmid by GeneartTM are shown in 
the Methods section, Figure 3.1, resulting in the plasmids pAP001 (expressing GFP) and 
pAP006 (RK-GFP). Both plasmids were amplified in NZY5α competent cells. Afterwards the 
plasmid DNA (pDNA) was isolated using the isolation NZYMiniprep kit and the final purity and 
concentration were determined by spectroscopic analysis (Table 5.1). An agarose gel analysis 
was performed to confirm that there had been no hydrolysis of the pDNA (Figure 5.1). 
 
Table 5.1 - pDNA concentration and purity of the plasmids used for the large scale production of GFP and RK-GFP. 
Plasmid (protein 
encoded) 
Elution DNA concentration 
(ng/μl) 
DNA purity 
A260/A280 A260/A230 
pAP001 (GFP) 
1st 76.4 1.76 1.76 
2nd 10.2 1.34 0.64 
pAP006 (RK-GFP) 
1st 152.4 1.80 1.81 
2nd 80.4 1.64 1.66 
 
The isolation of both plasmids resulted in the successful recovery of pDNA with high 
concentration and purity for the first elution step. The second elution of pAP006 was too 
diluted and it is not visible in the agarose gel (Figure 5.1, lane 3). The purification and isolation 
of pAP006 resulted in a single distinct band, observed in lane 9 for the 1st elution and lane 11 
for the 2nd elution (Figure 5.1). 
The resulting DNA samples of the first elution were used to transform BL21(DE3) cells to 
obtain final crude extracts containing the protein of interest. 
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Figure 5.1 - Agarose gel for pDNA analysis. Lanes: 1- NZYDNA Ladder III, 2- pAP001 (GFP) 1
st
 elution, 3- pAP001 (GFP) 
2
nd
 elution 9 -pAP006 (RK-GFP) 1
st
 elution, 11- pAP006 (RK-GFP) 2
nd
 elution, 13- NZYDNA Ladder III. Lanes 4-8, 10 
and 12 are empty. The gels present 0.8% agarose and were afterwards stained with Green Safe. 
 
5.4.2. Large scale production of GFP and RK-GFP 
The optimal conditions for the large scale production of GFP and RK-GFP in BL21(DE3) cells 
were studied previously [47]. Protein production was monitored by fluorescence intensity and 
OD600nm measurements (Figure 5.2) as well as SDS-PAGE analysis to visualize the relative 
amount of protein in the various fractions (Figure 5.3).  
 
 
Figure 5.2 - (a) GFP fluorescence and (b) optical density measurements after the induction (t=0) during the large 
scale expression of GFP and RK-GFP. 
We can see in Figure 5.2 that there is a correlation between the two measurements with 
the increasing induction time. The amount of protein produced by the cells increases with the 
time after induction and the amount of protein was significantly higher for GFP than for RK-
GFP. This is confirmed by the SDS-PAGE analysis, as shown in Figure 5.3. It also shows that we 
only have protein production after IPTG-induction. GFP has a molecular weight of 
approximately 29kDa (confirmed by the literature [104]) and RK-GFP of  approximately 31kDa. 
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The results from the analysis of the SDS-PAGE gels confirm the previous results: there is a 
higher production of GFP (GFP represents 25.7% of the total protein at 22h after induction) 
than of RK-GFP (8.8% of the total protein).  
 
 
Figure 5.3 - SDS-PAGE time course of large scale production of (a) GFP and (b) RK-GFP in E. coli BL21(DE3). Lanes: 
LMW – Low molecular weight maker; 0h – sample collected before induction; + xh – sample collected x hours after 
the induction. GFP is highlighted inside the box. The gels present 12.5% acrylamide and were stained with 
Coomassie Blue. 
Afterwards, the cells were harvested and lysed to obtain the final crude extract used for the 
screening assays in the next section.  
For the growing conditions used in this work GFP is presented as a soluble protein [47] and 
was produced mostly in its soluble form, as shown in Figure 5.4c. Lane PC in Figure 5.4a should 
contain the pellet sample obtained after the low speed centrifugation and as shown in Figure 
5.4c there is a very low amount of GFP present in this sample. However a large band is visible 
as a result from a contamination from the adjacent lane. The supernatant sample obtained 
after the ultracentrifugation step (SU) contains a high amount of GFP and was used for the 
screening assays. 
RK-GFP is produced mostly as soluble protein (Figure 5.4b). After the ultracentrifugation, 
most of the protein is located in the supernatant in high concentration. This sample was used 
for the screening assays. As shown before and as is corroborated in Figure 5.4c, RK-GFP was 
produced in less concentration. 
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Figure 5.4 – SDS-PAGE cellular fractionation gel of (a) GFP and (b) RK-GFP in E. coli BL21(DE3). Lanes: LMW – Low 
molecular weight maker; BI - sample collected before induction; AI – sample collected 2h after induction; PC – 
sample of ressuspended pellet after low-speed centrifugation; SC – sample of supernatant after low-speed 
centrifugation; PU – sample of ressuspended pellet after ultra centrifugation; SU – sample of supernatant after ultra 
centrifugation. The protein of interest is highlighted inside the box. The gels present 12.5% acrylamide and stained 
with Coomassie Blue. (c) Amount of GFP (in mg) present in each sample of the previous gels. 
 
 
5.5. Magnetic particle selection and characterization  
Magnetic particles were produced by the co-precipitation method and their surface was 
chemically modified with the affinity ligands LA-A4C7, NA/LR-A7C1 and NR-A5C2. The particles 
were then characterized according to their hydrodynamic diameter and zeta potential. 
DLS is a widely used technique for the determination of average particle size in a colloidal 
solution [123]. This technique is based on the interaction between a source of light and the 
particles present in a solution. The scattering effect depends on the Brownian movements of 
the particles in solution, which correlates with the translational diffusion coefficient. The 
Stokes-Einstein equation is used to  estimate the mean size distribution of the particles within 
the sample [124]. This measurement will depend on the particle size, surface structure, 
concentration and medium. 
 
The dispersed particles in a colloidal sample will have a charged surface due to ionization or 
adsorption of charged species. Therefore, there will be an electric double layer surrounding 
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the particle: the Stern layer where ions are more strongly attached, and an outer, more 
diffused layer. The zeta potential relates with the potential at the slipping plane, a notional 
boundary where the particles and the ions of the outer layer form a stable entity. 
The magnitude of the zeta potential can be related with the potential stability of the 
colloidal system. If a large zeta potential is measured (higher than +30mV or lower than -
30mV), the repulsion forces will prevail and the particles will remain dispersed in solution. For 
zeta potential values in between, the particles tend to flocculate. The zeta potential is 
influenced by temperature, ionic strength and particularly by pH [125].  
 
In this section we analyze the hydrodynamic diameter and zeta potential of the MNP_DEX, 
MNP_DEX_NH2 and the aminated-supports functionalized with the affinity ligand for GFP 
(MNP_DEX_NH2_LA-A4C7) and for RK-GFP (MNP_DEX_NH2_LR-A7C1), as well as negative 
controls (MNP_DEX_NH2_NA-A7C1) for GFP, and MNP_DEX_NH2_LR-A5C2 for RK-GFP) [47]. 
 All samples were measured using the concentration 0.05mg/ml in deionized water (pH 
5.80). The results are shown in Figure 5.5. 
 
 
Figure 5.5 – (a) Hydrodynamic diameter (nm) and (b) zeta potential (mV) results for the magnetic supports used for 
the screening assay of GFP and RK-GFP (n=3). 
MNPs synthesized by the co-precipitation methods usually have individual magnetic cores 
of 10-12nm in diameter [22]. However, their small size and large surface area tend to induce 
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aggregation [7]. Furthermore, additional functionalizations contribute for the increase of this 
property, as seen in Figure 5.5a. The coating material contributes for the increase of the 
particle diameter, due to the formation of bridges between coating molecules [22]. APTES can 
crosslink and form extended networks, contributing for the increase of the MNPs’ diameter. 
Additional Ugi functionalization uses glutaraldeyde, which can react with two amine groups 
present on the surface of two adjacent MNPs and contribute for the formation of larger 
aggregates. If we attend to the error bars for the results of the ligand-functionalized MNPs 
(Figure 5.5a) we can see that their diameter is quite similar. However, DLS is a reliable 
technique for the measurement of homogeneous colloidal solutions with particle size lower 
than 1μm, which is not the case. Larger particles limit the DLS technique to diluted samples 
due to the contribution from multiple scattering [123]. Therefore, the results obtained by this 
technique are not very reliable and different equipments should be used for the determination 
of the size.  
 
The zeta potential can be used to confirm the functionalization of the particle surface 
(Figure 5.5b).  Bare magnetite nanoparticles have a isoelectric point of 6.8 [3], which would 
result in a positive zeta potential value. When coated with the neutral polysaccharide dextran, 
this value approaches zero [2]. Aminated-MNPs present low positive values of zeta potential, 
due to the amine groups at the surface of the MNPs [22]. The zeta potential of the 
functionalized-MNPs will be result of the pKa of the compounds that form the ligands. For LA-
A4C7- and NR-A5C2-functionalized MNPs, the zeta potential is very similar to the non-
functionalized MNPs. This could mean the lack of functionalization – which is not the case as 
shown in the next section – or a low yield of ligand coupling. On the other hand, the low pKa of 
the carboxyl groups in amine A7 contributes to lower the zeta potential of 
MNP_DEX_NH2_NR/LR-A7C1.  
Furthermore, all supports present zeta potential values between -30mV and +30mV, which 
confirms the low stability of the supports and aids the formation of large aggregates (see 
Figure 5.5a). However, for the purpose of protein purification large aggregates facilitate their 
recovery by a relatively weak permanent magnet. 
 
The supports characterized above have been used for the purification of GFP (section 5.6) 
and RK-GFP (section 5.7) from crude extracts. 
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5.6. MNP as solid supports for the purification of GFP   
For the purification of GFP, MNP_DEX_NH2 were functionalized with LA-A4C7, the Ugi 
ligand that has been identified to display affinity towards GFP [47]. As negative controls, 
MNP_DEX_NH2 were used during the screening, as well as MNP functionalized with NA-A7C1, 
due to its low affinity for GFP [47]. 
 
5.6.1. Solid support functionalization and ligand leaching 
The amine A4 is 1-pyrenemethylamine which has a fluorescence signal (ʎexcitation=485nm 
and ʎemission=535nm) – see  Figure 5.6. It shows a clear fluorescence sign for MNP_DEX_NH2_LA-
A4C7, which is absent for the non-functionalized MNPs. This qualitative analysis cannot 
confirm 100% that the Ugi ligand is present on the MNP_DEX_NH2, only that pyrene molecules 
are present on the surface of the MNPs.  
 
 
Figure 5.6 - Fluorescence microscopy results. Bright field images of MNP_DEX_NH2 (a) and MNP_DEX_NH2_LA-A4C7 
(b). Fluorescence microscopy images (exposition time=1s) of MNP_DEX_NH2 (c) and MNP_DEX_NH2_LA-A4C7 (d). 
 
Due to the pyrene’s fluorescence in the same range as GFP, ligand leaching could influence 
the results. To determine this possibility a screening assay was performed using PBS instead of 
crude extract in the first step. All washes were quantified and the pyrene present was 
quantified using a pyrene calibration curve. No pyrene leaching was identified during the 
assay. 
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5.6.2. GFP binding to the solid supports 
For the screening assay, the three supports described previously (MNP_DEX_NH2, 
MNP_DEX_NH2_LA-A4C7 and MNP_DEX_NH2_NA-A7C1) were tested simultaneously for the 
purification of GFP. Different conditions have been tested: (1) MNP concentration, (2) the 
crude extract loading concentration and (3) the amination of the supports. The results will be 
discussed regarding two aspects: binding (Figure 5.7) and elution (Figure 5.8).  
 
 
Figure 5.7 - Screening results for GFP binding regarding GFP (a, c, e and g) and total protein (b, d, f and h) with the 
following supports: MNP_DEX_NH2 (MNP), MNP_DEX_NH2_LA-A4C7 (MNP-LA) and MNP_DEX_NH2_NA-A7C1 (MNP-
NA). The first concentration in the legend is the concentration of MNP used, the loading concentration refers to the 
GFP concentration in the loading solution. 
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Influence of the MNP concentration  
For this purpose two loading conditions have been tested: 75±8μg GFP/ml (Figure 5.7a and 
Figure 5.7b) and 159±6μg GFP/ml (Figure 5.7c and Figure 5.7d). It is important to refer that the 
MNPs used have the same amination content (140umol NH2/g support). So assuming that we 
have a batch with a homogenous functionalization, we can test the effect of changing the 
initial MNP concentration.  
 
For the first loading condition, two MNP concentrations were tested: 20mg/ml and 
40mg/ml. A higher concentration of MNPs translated into a higher concentration of ligand LA-
A4C7, resulting in a higher percentage of GFP binding. A higher ligand density translates into a 
higher protein adsorption [19]. Although the coating should contribute to lower the non-
specific adsorption (as observed by a higher binding of IgG to bare MNPs vs gum arabic-coated 
MNPs [22]), the coating can contribute for non-specific binding and decrease the selectivity of 
the purification process [113]. This can explain the high amount of protein that binds to all the 
solid supports.  
On the other hand, screening the crude extracts with 20mg/ml resulted in less GFP bound 
to the solid support MNP_DEX_NH2_LA-A4C7 than to the controls. The low amount of ligand 
does not allow a specific binding of GFP. 
 
The second loading condition tested (159±6μg GFP/ml) confirmed the previous results. A 
larger concentration of MNP translates into a higher amount of ligand and consequently a 
higher amount of GFP bound to the support.  
Ditsch et al [7] have described a successful protein purification system using only 1mg 
magnetic adsorbent/ml.  Although handling higher MNP concentration does not present any 
immediate disadvantage [122], working with a very high concentration of particles is hard to 
handle. Therefore, 40mg/ml is the best tested concentration for protein purification purposes. 
 
Influence of the concentration of the loading sample 
Herein we compared for the same concentration of MNP (40mg/ml), different loading 
concentrations: 81µg GFP/ml and 155µg GFP/ml (Figure 5.7e and Figure 5.7f).  
A higher concentration of GFP in the loading solution does not result in a higher amount of 
GFP bound to the supports. This can be explained due to the higher concentration of other 
proteins presented in the more concentrated loading solution (confirmed by the BCA results, 
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Figure 5.7f). A higher percentage of non-specific interactions with other protein present in the 
crude extract do not allow GFP to bind to LA-A4C7. 
Therefore, for a similar assay with the same incubation conditions, a more diluted loading 
solution allowed a higher percentage of GFP bound to the MNP_DEX_NH2_LA-A4C7 support. 
 
Influence of the level of MNP amination  
Two different MNP samples have been tested, which had different amination contents 
(Figure 5.7g and Figure 5.7h) for similar loading concentrations (86±8mg GFP/ml). The amine 
density on solid supports is strongly influenced by reaction conditions [22], which makes it 
complicated to obtain evenly aminated  supports. Performing the Kaiser test, we determined 
that the first batch of MNP had 140±4μmol NH2/g support (from which all previous results are 
from) and the second batch had 271±52μmol NH2/g before ligand attachment. If we assume 
that we have 100% amine functionalization, it confirms the results: a higher amination (which 
corresponds to a higher concentration of ligand at the surface of the MNPs) results in a higher 
amount of GFP bound to the solid support.  
 
The determination of ligand concentration at the surface of the MNPs is a complicated task.  
Authors have determined ligand density through the extent of epoxy-activation of the 
agarose beads used as solid support [15,19]. Similarly, we tried to use the amine content to 
determine ligand density. The results are summarized in Table 5.2. 
 
Table 5.2 - Degree of amination before and after ligand coupling for both batches of MNP_DEX_NH2_LA-A4C7 and 
other relevant information. 
MNP_DEX_NH2_LA-A4C7 
 Batch 1 Batch 2 
Amination   
     Before functionalization 
    (μmol NH2/g support)  
140±4 271±52 
     After functionalization 
    (μmol NH2/g support) 
90±1 89±1 
   
Reacted amines  
(μmol NH2/g support) 
49 182 
Percentage of 
functionalization (%) 
35 67 
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If we assume that the amines that react during the Ugi reaction are in a 1:1 proportion to 
the glutaraldeyde coupling reaction, the concentration of reacted amines will correspond to 
ligand concentration. This is still according to the results for GFP binding: a higher 
concentration of ligand translates into a higher concentration of GFP bound to the particles. 
On the other hand, a higher amount of amines can favor the reaction between the compounds 
in solid-phase and the compounds in liquid-phase, which will favor a higher functionalization 
percentage. 
Unfortunately the Kaiser test can only be used as a semi-quantitative method and has 
several limitations, making it difficult to predict ligand concentration. It is performed under 
quite harsh reaction conditions (sample incubation at 100°C), which can reveal hidden amines 
or allow the release of other interfering components. If these conditions are harsh enough to 
promote ligand release, we can be measuring more free amines and increase the percentage 
of functionalization. 
 
 
Based on the previous results, we can conclude that the best conditions for GFP binding 
would be to use a higher concentration of MNP (40mg/ml), with a higher amination content 
(271μmol NH2/g support) and a more diluted loading solution (81μg GFP/ml). This is confirmed 
by the elution results, which will be presented below. 
 
 
5.6.3. GFP elution from the solid supports 
The elution conditions are dependent of each system, protein to purify, affinity ligand and 
solid-support used. For GFP elution, the magnetic microbeads μMACS® (Milteniyi) uses a 
denaturing elution buffer, containing low concentrations of dithiothreitol and SDS, at pH6.8, 
while the GFP-TRAP® uses an elution buffer with low pH (pH=2). 
For all experimental conditions tested and presented in Figure 5.7, two elution conditions 
were screened in this work: 0.1mM glycine-NaOH pH9 (Figure 5.8a) and 0.1mM glycine-NaOH 
pH9 50% (v/v) ethylene glycol (Figure 5.8b), as previously studied in [47].  
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Figure 5.8 - Screening results for GFP elution with the following supports: MNP_DEX_NH2 (MNP), 
MNP_DEX_NH2_LA-A4C7 (MNP-LA) and MNP_DEX_NH2_NA-A7C1 (MNP-NA), for (a) elution condition A and (b) 
elution condition B. The first concentration in the legend is the concentration of MNP used, the loading 
concentration refers to the GFP concentration in the loading solution. 
 
The best elution condition to elute GFP was 0.1mM glycine-NaOH pH9 50% (v/v) ethylene 
glycol (Figure 5.8b). Ethylene glycol is responsible for disrupting hydrophobic interactions 
[126]. This result is in accordance with the results from section 4 – the interaction between 
GFP and LA-A4C7 is mainly hydrophobic. All tested conditions (except for the first (Figure 5.8b, 
in blue, due to low GFP binding) resulted in roughly 25% elution of the GFP bound to the solid 
support. The experiment where we had the most GFP eluted (Figure 5.8b in orange) 
corresponds to the experiment were we had the most GFP bound to the MNPs.  
An important remark has to be done about these elution results, as ethylene glycol 
influences the GFP fluorescence, increasing the measured fluorescence [47]. Therefore, a 
lower amount of GFP has been eluted compared to the results in Figure 5.8b. 
 
Another important parameter for protein purification is the purity of the protein during 
elution. His-GFP can be purified by a Ni-NTA column with a final purity over 95% [127]. 
BCA does not have enough resolution to quantify the low amount of protein that was 
eluted (quantification limit of 0.2mg/ml), while GFP allows a quantification limit of 
0.0001mg/ml (according to the calibration curve used in this work). SDS-PAGE was used to 
evaluate the purity of the eluted GFP (Figure 5.9). 
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Figure 5.9 - SDS-PAGE analysis of the molecular weight marker (LMW) and flow-through (FT), first elution sample 
with elution condition A (EA) and condition B (EB) for all the supports tested. Results regarding 40mg MNP/ml, 
loading=91.6μg GFP/ml, 271μmol NH2/g support (orange, in Figure 5.7 and Figure 5.8). The GFP corresponding 
bands are shown in a box. Gels stained by silver staining. 
 
Figure 5.9 corresponds to the experiment where the best conditions were tested: 40mg 
MNP/ml of the most aminated batch (217μmol NH2/g support) and less concentrated loading 
solution (92μg GFP/ml) - regarding Figure 5.7g and Figure 5.7h. No GFP was eluted when using 
the negative control particles. Purity and yield results regarding this system are summarized in 
Table 5.3.  
 
Table 5.3 – Percentage of recovery, purity and yield of GFP calculated from the results presented in Figure 5.9. 
Sample 
GFP Recovery 
(%) 
Purity 
(%) 
Yield 
(%) 
MNP_DEX_NH2_LR-A7C1 EA 0 [1] 65 0 [1] 
MNP_DEX_NH2_LR-A7C1 EB 48 86 44 
[1] Although there is a visible band corresponding to GFP in the MNP_DEX_NH2_LR-A7C1 EA lane, the concentration 
was not quantifiable or measurable by fluorescence intensity. 
 
The SDS-PAGE gel allows a qualitatively analysis that we have more protein binding to 
MNP_DEX_NH2_LA-A4C7 than to the negative supports. The selectivity of this system is low 
(12%), as LA-A4C7 also binds to other proteins present in the crude extract. We have the most 
amount of GFP eluting from the LA-A4C7 functionalized-MNPs when treated with elution 
condition B. Although some other proteins are eluted when using elution condition B and we 
only achieved a yield of 44%, we were able to retrieve 46% of the total GFP bound to the 
support, with a purity of 86%. Although this value of purity is still low for an affinity-based 
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purification system, it is quite high for a novel system using a novel solid-support, where the 
used elution conditions have not been optimized.  
 
 
5.7. MNP as solid supports for the purification of RK-GFP   
The RKRKRK-tag has shown promising results for the purification of tagged-GFP using 
agarose beads [47]. For the purification of RK-GFP, aminated dextran-coated magnetic 
nanoparticles (MNP_DEX_NH2) were functionalized with LR-A7C1, the Ugi ligand that has been 
identified to display affinity towards RK-GFP [47]. As negative controls, MNP_DEX_NH2 were 
used during the screening, as well as MNP functionalized with NR-A5C2, due to its low affinity 
for RK-GFP [47]. 
Based on the GFP screening results, an initial concentration of 40mg/ml of MNPs has been 
used for this screening. Only one loading condition was tested (12μg RK-GFP/ml), and the 
amount of RK-GFP and total protein bound and eluted from the magnetic supports is shown in 
Figure 5.10 and Figure 5.11, respectively. 
 
 
Figure 5.10 - Screening results for RK-GFP binding regarding (a) RK-GFP and (b) total protein with the following 
supports: MNP_DEX_NH2 (MNP), MNP_DEX_NH2_LR-A7C1 (MNP-LR) and MNP_DEX_NH2_NR-A5C2 (MNP-NR). 
Experimental conditions: 40mg MNP/ml, loading 12μg RK-GFP/ml, 271μmol NH2/g support. 
Contrary to what we observed for the purification of GFP, we observed a higher amount of 
GFP binding to the non-functionalized MNPs than to MNP_DEX_NH2_LR-A7C1. (Figure 5.10a), 
as well as non-specific binding to total protein (Figure 5.10b). This system is even less selective 
than the affinity system LR-A7C1/GFP, with only 8% selectivity. We could only bind 
0.81±0.03mg RK-GFP/g support, while we had a binding maximum of 3.13mg GFP/g support. 
This can be for two reasons. On one hand, the ligand LR-A7C1 has a lower affinity for RK-GFP 
than LA-A4C7 for GFP. On the other hand, the lower concentration of RK-GFP in the crude 
extract facilitates the unspecific binding of other proteins, limiting the contact between RK-
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GFP and the ligand. This can be supported by the results obtained for the study of the loading 
concentration influence for the GFP binding assay: a higher concentration of loading solution 
did not result in a higher amount of GFP bound (see Figure 5.7e). 
 
However these conditions should be optimized in order to obtain a higher amount of RK-
GFP bound, as only 10% of the RK-GFP present in the loading solution was bound to 
MNP_DEX_NH2_LR-A7C1. 
 
 
Figure 5.11 - Screening results for RK-GFP elution with the following supports: MNP_DEX_NH2 (MNP), MNP 
functionalized with ligand LR-A7C1 (MNP-LR) and MNP functionalized with ligand NR-A5C2 (MNP-NR), for elution 
condition A (EA) and elution condition B (EB). 
 
Figure 5.11 summarizes the elution results for RK-GFP. The elution conditions tested were 
PBS pH 7.4, 500mM arginine (EA) and 0.1M glycine-NaOH pH 11, 150mM NaCl (EB). Contrary 
to the GFP results (Figure 5.8), we had elution in all cases, including for the negative controls. 
However, we can see that we had a higher amount of RK-GFP eluted from MNP_DEX_NH2_LR-
A7C1 in comparison with the negative controls. 
A higher concentration of RK-GFP was eluted when using EA, which is based on 
competition. These results are not according to the ones obtained in the modeling studies 
(Section 4) - the interactions were mainly between LR-A7C1 and the lysine residues in the tag. 
However, contrary to the results regarding GFP/LA-A4C7, we did not obtain very high 
percentages of interaction and it may not be able to explain theoretically the main interactions 
between LR-A7C1 and RK-GFP. However we could retrieve 70% of the RK-GFP bound to 
MNP_DEX_NH2_LR-A7C1.  
SDS-PAGE analysis was performed to access RK-GFP purity in the elution factions (Figure 
5.12).  
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Figure 5.12 - SDS-PAGE analysis of the molecular weight marker (LMW) and flow-through (FT), first elution sample 
with elution condition A (EA) and condition B (EB) for all the supports tested. Gels stained by silver staining. 
We can see that we have RK-GFP elution in the lanes corresponding to the negative 
controls (non-functionalized MNPs). The calculated purity and yield for RK-GFP in the different 
lanes is shown in Table 5.4. 
 
Table 5.4 - Percentage of recovery, purity and yield of RK-GFP calculated from the results presented in Figure 5.12.. 
Sample 
RK-GFP 
Recovery (%) 
Purity 
(%) 
Yield 
(%) 
MNP_DEX_NH2 EA 25 21 0.9 
MNP_DEX_NH2 EB 11 36 0.3 
MNP_DEX_NH2_LR-A7C1 EA 58 62 6 
MNP_DEX_NH2_LR-A7C1 EB 38 78 3 
MNP_DEX_NH2_NR-A5C2 EA 0 0 0 
MNP_DEX_NH2_NR-A5C2 EB 0 0 0 
 
A less pure amount of RK-GFP was recovered after elution of non-functionalized support. 
The elution of the LR-A7C1 functionalized support resulted in a higher purity of RK-GFP, 
although lower than for GFP elution (see Figure 5.9). On the other hand, although elution 
condition A resulted in a higher yield of RK-GFP eluted, it displays a lower purity.  
The low values obtained are result of using a novel solid-support, for which the conditions 
have not been optimized. 
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5.8. Static partition equilibrium studies for the determination 
of binding constants 
The binding constants that describe the reversible interaction between an affinity ligand 
and a target protein in an affinity purification method are the affinity binding constant (Ka) and 
the maximum binding capacity of the support (Qmax), usually obtained from the application of a 
Langmuir model to data from partition equilibrium studies (Figure 5.13). 
 
 
Figure 5.13 - Binding isotherms for the affinity pairs (a) GFP and LA-A4C7 and (b) RK-GFP and LR-A7C1. The 
experimental results have been fitted to the Langmuir model (in red). 
The binding isotherm for GFP binding to LA-A4C7 (Figure 5.13a) is linear for lower 
concentrations of GFP and it starts to reach the maximum binding capacity. The isotherm for 
RK-GFP (Figure 5.13a) displays a more linear profile due to the lower concentration of RK-GFP 
present in the crude extracts. The Langmuir isotherm is the most popular model employed in 
affinity chromatography and is described by Equation 5.1 [128]: 
 
   
             
        
                    
 
where q is the bound protein per mass of support (mg/g support) and C corresponds to the 
concentration of unbound protein in equilibrium (mg/ml). The Langmuir isotherm assumes 
that all binding sites are identical and that each one retains one target molecule and have 
uniform and independent energies of adsorption [128]. The resulting constants are 
summarized in Table 5.5.  
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Table 5.5 - Binding constants for the studied affinity systems – GFP/LA-A4C7 and RK-GFP/LR-A4C7 – with different 
solid supports and by theoretical study after fitting with Langmuir model. 
Solid support  
    and Affinity pair 
Ka  
(×105 M-1) 
Qmax (mg/g) R
2 
Magnetic nanoparticles 
    GFP and LA-A4C7 
    RK-GFP and LR-A7C1 
 
0.83 
3.21 
 
3.99±1.61 
1.58±0.27 
 
0.99 
0.98 
Agarose beads ([47]) 
    GFP and LA-A4C7 
    RK-GFP and LR-A7C1 
 
2.38 
2.45 
 
1.02±6.85 
0.47±0.57 
 
0.89 
0.99 
None (modeling study) 
   GFP and LA-A4C7 
    RK-GFP and LR-A7C1 
 
1.43 
4.43 
- - 
 
The Ka values obtained were within the range for suitable purification methods: high 
specificity affinity purification methods display Ka within 103-109M-1 [94]. Ka values are within 
the same order of magnitude as the values obtained for agarose beads as the solid support 
and for the ligand in its free form (modeling study). Natural affinity systems usually display 
higher Ka values (e.g. glutathione/glutathione-S-transferase [129], staphylococcal protein 
A/IgG [130] with 105 and 108 M-1, respectively). Affinity systems with biomimetic ligands 
usually display lower Ka (e.g. triazine-based ligands 22/8 [18] and 8/7 [19] and Ugi-based 
ligand [15] that bind human IgG with a Ka of 105, 104 and 106 M-1, respectively. Compared to 
these literature examples, we can state that both affinity pair described has a very promising 
Ka value for a protein purification system, particularly RK-GFP/LR-A7C1. 
 
Using MNP as a solid support has resulted in higher values of Qmax than when using agarose 
beads. However it is complicated to use the maximum capacity of the support as we are 
limited to the amount of GFP presented in the crude extracts. However, using a more diluted 
loading solution has shown to increase the binding of GFP to the solid support (see Figure 
5.7e).  
The obtained values of Qmax are low when compared with other affinity systems described 
in the literature. The magnetolipossomes of Bucak et al [122] or the polymer-coated MNPs of 
Ditsch et al [7] present a value of 800mg protein/g particles and 640mg/g, respectively. In 
general, biomimetic affinity systems also display lower Qmax values. The biomimetic Ugi-based 
ligands for the purification of IgG presented a value of 16mg/ml agarose [15]. However, we 
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have to have in mind that the magnetic supports tested had an unspecific behavior towards 
GFP binding. 
 
 
5.9. Conclusions and Future Directions 
Herein we have described the application of novel affinity ligands for the purification of GFP 
and tagged-GFP using magnetic beads.  
 
First, we have amplified and isolated successfully pure pDNA, which was confirmed by 
spectroscopic and gel electrophoresis analysis. Furthermore, we were able to obtain a crude 
extract containing GFP or RK-GFP using E. coli BL21 as host. These crude extracts were 
successfully used for the purification assay with magnetic particles. 
 
Magnetic particles were functionalized with the same lead and negative control affinity 
ligands employed in Chapter 3, namely LA-A4C7 for GFP studies and LR-A7C1 for RK-GFP 
studies.  
 
When employing particles MNP_DEX_NH2_LA-A4C7, we were able to bind and elute GFP at 
different experimental conditions. Based on the results, we concluded that the best conditions 
for GFP binding were a higher concentration of MNPs (40mg/ml) with a higher amination 
content (271μmol NH2/g support), and a more diluted loading solution of protein (81μg 
GFP/ml). However we have observed that the magnetic support presents an unspecific binding 
behavior towards GFP binding, contributing for the binding of a large amount of other proteins 
present in the crude extract.  
Still, we were able to selectively elute GFP from the LA-A4C7 functionalized-MNPs. The best 
elution condition for GFP elution was 0.1mM glycine-NaOH pH9 50% (v/v) ethylene glycol, as 
ethylene glycol contributes for the disruption of the hydrophobic interactions between the 
lead ligand and GFP. However the yield obtained was low (44%) despite the fact that the purity 
of the eluted fractions was quite high (81%).  
It is complicated to perform a comparison between our magnetic-based system for GFP 
purification and other commercially available kits (μMACS®, from Milteniyi; GFP-TRP®, from 
Chromotek), due to the lack of information provided by the suppliers. However, both suppliers 
claim low non-specific binding of their systems, which is a clear advantage over the system 
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described in this work (selectivity of 12%). Both systems rely on the affinity between an anti-
GFP antibody and GFP, with quite different elution conditions (μMACS® (Milteniyi) uses a 
denaturing elution buffer at pH6.8 and GFP-TRAP® uses an elution buffer with low pH (pH=2). 
 
The best conditions described above (40mg MNP/ml) with a higher amination content, and 
a more diluted loading solution of protein) have been tested for the purification of RK-GFP. 
The LR-A7C1 functionalized-MNPs also showed low specificity towards RK-GFP, as lower purity 
and yield of RK-GFP eluted than for the GFP/LR-A4C7 system. The best elution condition for 
RK-GFP elution was PBS pH 7.4, 500mM arginine, in which the arginine competes for the same 
binding locations as the tag-residues of the protein.  
 
Most conditions that have been chosen due to its good results when using agarose beads 
[47]. However different solid supports require different optimized conditions. A next possible 
route would be to optimize binding and elution conditions in order to increase yield and final 
protein purity while using MNPs as a solid support. These optimizations include different 
incubation and elution buffers, with different ionic strengths, pH values or others chemicals 
that can disrupt hydrophobic interactions or induce competition.  
 
Partition equilibrium studies have been performed and the experimental results were fitted 
according to a Langmuir isotherm. For GFP/LA-A4C7 and RK-GFP/LR-A7C1 affinity systems we 
achieved quite promising Ka values (0.83×105 and 3.21×105M-1, respectively), comparable to 
the studies done for the same affinity pairs using agarose beads [47] and in the theoretical 
study (Section 4), as well as with other affinity systems described in the literature. On the 
other hand, Qmax values were quite low. These values can be correlated with the results 
achieved in this chapter, specifically for the low amount of RK-GFP bound to the magnetic 
supports. Although the Langmuir isotherm was chosen as the best fitting model it might not be 
the most appropriated. Other isotherm models could have resulted in better Ka and Qmax 
results for this affinity system. 
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6.1. Objective 
We aimed to develop novel antimicrobial devices and to assess their antimicrobial potential 
based on a new HTS method. For this purpose magnetic nanoparticles were functionalized 
with an antimicrobial peptide by two separate methods and tested against Gram-positive and 
Gram-negative bacteria.  
The chosen antimicrobial peptide for this work was RWRWRW. The antimicrobial activity of 
(RW)x has been described by many authors  as well as its low toxicity against eukaryotic cells 
[32,36,131]. 
 
 
6.2. Peptide immobilization onto MNPs and characterization 
Two different methods for peptide immobilization onto MNPs were evaluated and 
compared: via sulfo-coupling and via EDC-coupling, as schematically represented in Figure 3.4 
and Figure 3.5, respectively. Different biopolymers were used for coating, as dextran, PEG and 
a double coating of silica (Si) and dextran. 
The sulfo-coupling relies on the use of sulfo-SMCC, a water-soluble amine-to-sulfhydryl 
crosslinker. It provides a 8.3Å spacer arm between the two reactive groups – the amine groups 
at the surface of the MNPs and the thiol group at the N-terminal of the Cys-PP-RWRWRW 
peptide (Cys-(RW)3). The EDC-coupling relies on the use of two compounds: EDC and NHS. EDC 
is a water-soluble carbodiimide crosslinker. It allows a neutral linkage between two reactive 
groups – the amine groups at the surface of the MNPs and the carboxyl group of the 
RWRWRW peptide ((RW)3). The NHS allows the formation of a more stable intermediate of the 
coupling reaction. 
The DLS and zeta potential characterization of the resulting solid supports is shown in 
Figure 6.1. 
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Figure 6.1 - a) Hydrodynamic diameter (nm) and (b) zeta potential (mV) results for the magnetic supports and 
peptides used for the antimicrobial assay (n=3). 
As described in the previous section, additional functionalization contribute for the increase 
of the hydrodynamic diameter, as seen in Figure 6.1a. A similar diameter has been reported for 
the dextran- and PEG-coated MNPs after peptide tethering.  
 
The zeta potential for the peptides (RW)3 and Cys-(RW)3 is positive (Figure 6.1b, in orange), 
which would be expected due to the cationic behavior of the peptide. The positive charges are 
vital for the peptide’s antimicrobial mechanism [36].  
On the other hand, all functionalized-solid supports present zeta potential values between -
30mV and +30mV, which is a confirmation of the low stability of the supports. The main 
disadvantage of larger particles is the decreased specific surface area available. However the 
larger aggregates allow the facilitated magnetic removal of the MNPs from solution. Further 
observations related with the zeta potential of the functionalized-solid supports while be 
discussed below. 
 
For an initial comparison of the two methods of functionalization we have compared the 
percentage of immobilization of the peptide onto MNP with different coatings. The percentage 
of immobilization is summarized in Table 6.2. 
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Table 6.2 - Percentage of functionalization for the different coated-MNP used as antimicrobial devices. 
Biopolymer 
coating 
Functionalization 
method 
Peptide % Immobilization 
% Immobilization 
(negative control) 
Dextran Sulfo-coupling Cys-(RW)3 92±4 (n=3) 46 (n=1) 
Si-dextran Sulfo-coupling Cys-(RW)3 36 (n=1) - 
Si-PEG 
Sulfo-coupling Cys-(RW)3 92 (n=1) 0 (n=1) 
EDC-coupling (RW)3 18 (n=1) 5 (n=1) 
PEG 
Sulfo-coupling Cys-(RW)3 99 (n=1) 50 (n=1) 
EDC-coupling (RW)3 42±28 (n=3) 4 (n=1) 
Note: n represents the number of times that the strategy was tested. The results with (-) were not 
performed in this work. 
 
The first strategy used was to functionalize MNP_DEX_NH2 with Cys-(RW)3, which yield a 
high percentage of immobilization (92%). However when these particles were tested against E. 
coli we did not observe the expected antimicrobial effect (see section 6.3). In fact, a low 
positive zeta potential value has been measured for the MNP_DEX_NH2_Cys-(RW)3 (Figure 
6.1b) and a more positive charge should be determinant for the interaction with the negatively 
charged bacterial membrane [132]. On the other hand, although the percentage of 
immobilization was high, it appeared that the peptide was not immobilized in such a way that 
could facilitate its interactions with the microbial cell walls. In addition, the amount of 
“correctly” immobilized peptide is not known. It is possible that the cysteine residue from Cys-
(RW)3 is interacting directly with the iron oxide surface, which would hidden the antimicrobial 
group. Cysteine has been described to absorb to magnetite in a wide range of pH and ionic 
strengths [133]. A negative control has been performed, where the MNP_DEX_NH2 were 
incubated with the peptide in the absence of the cross-linker, and the results confirm that the 
peptide was being attached to the magnetic core via the cysteine residue.  
 
MNP_PEG_NH2 were also functionalized with the antimicrobial peptide via sulfo-coupling 
with a high percentage of functionalization (over 90%) and did not show any antimicrobial 
effect against E. coli (data not shown). The negative control performed with these particles 
demonstrated that the peptide was interacting with the magnetic surface. The AMP was not 
available to interact with the microbe membrane and would not contribute for its disruption, 
which is supported by the low positive zeta potential (Figure 6.1b). 
A new double coating was tested: silica/dextran- and silica/PEG-coated MNPs were 
functionalized with Cys-(RW)3 via sulfo-coupling. We expected that the double coating would 
decrease the probability of the cysteine interacting with the MNP surface. The negative control 
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performed with the silica/PEG-coated MNPs supports this hypothesis: no peptide interacts via 
cysteine, as the double coating provides a better coverage of the magnetic core.  
 
To overcome the described disadvantages a different functionalization strategy was used: 
via EDC-coupling. Poly(ethylene glycol) (PEG) is described by its anti-adhesive [44] properties 
and it is used as coating for anti-fouling surfaces [4,44]. PEG contributes for MNP stability 
when used as coating - confirmed by higher zeta potential values (Figure 6.1b). Therefore only 
PEG- and silica/PEG-coated MNP were tested. The negative controls performed confirm that 
there is a low non-specific coupling of the peptide to these particles. However, as described in 
Table 6.2 EDC-coupling seems a non-reproducible method for (RW)3 coupling due to the 
characteristics of the peptide. The EDC-coupling strategy is based on the bond formation 
between a carboxylic group and an amine group. The amines in solution are not only the 
amines from the aminated support but also the amines from the arginines’ side chains of the 
peptide, which leads to a cross-link reaction within the peptides present in solution, 
contributing to lower the available free peptide in solution. On the other hand, if the mesh of 
peptide is immobilized it may not have the correct conformation to disrupt the microbial 
membrane or the concentration we are expecting may not be correctly available. The EDC-
coupling strategy must be further optimized to be used for the immobilization of this peptide.  
However the functionalization of the PEG-coated MNPs has yield particles which have 
demonstrated antimicrobial activity, as shown in Figure 6.3 and Figure 6.4. It also has a more 
positive zeta potential value than the MNP_PEG_NH2_Cys-(RW)3 (see Figure 6.1b), which 
supports the antimicrobial activity results. 
 
 
6.3. Testing magnetic antimicrobial devices against E. coli K12 
and B. subtilis 168 
Two bacteria strains have been tested against antimicrobial devices in this work: E. coli K12 
and B. subtilis 168. The negatively-charged bacterial cell membrane and the outer 
lipopolysaccharide layer of Gram-negative are the perfect target for the electrostatic 
interaction with the peptide  [134]. 
 
The peptide (RW)x alone has shown to display antimicrobial activity against E. coli [32,131] 
and B. subtilis [134]. The chain length of (RW)x peptides correlates with the antimicrobial 
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activity and the hexapeptide has been described to exhibit a strong antimicrobial activity [36]. 
To confirm these results both strains used in this work have been tested against this peptide 
(Figure 6.2). 
A very high concentration of the peptide has been used in this work compared to the 
concentrations reported in the literature – a maximum of 0.08mM [131], 0.15mM [134] and 
0.20mM [32]. 
 
 
Figure 6.2 - (a) E. coli (EC) and (b) B. subtilis (BC) growth behavior in shaking flasks in the presence of (RW)3 
antimicrobial peptide. The antimicrobial agent was added at (a) t=60min and (b) t=90min. 
Figure 6.2 clearly shows that (RW)3 affects bacteria growth. The minimum inhibitory 
concentration (MIC) has not been determined in this work, but in a similar study [47] it was 
determined that 0.25mM of (RW)3 was enough to inhibit the growth of E. coli K12. Although 
the action of this AMP has not been reported against B. subtilis, a lower concentration would 
be expected due to the lack of the outer layer – a lower MIC has been reported against Gram-
positive S. aureus compared to E. coli and other Gram-negative bacteria [36,134]. 
We observe a bacteriostatic effect of the peptide for both strains – the peptide inhibits the 
growth of the bacteria present in solution. Although this peptide is described as having a 
bactericidal effect [32], the protocol to derive this observation was different, which was based 
on the inoculation of agar plates after 3h incubation of E. coli with the (RW)3 peptide. This 
protocol may not reflect adaptation mechanisms that may occur.  
 
Herein we tested some of the functionalized magnetic supports described above for their 
antimicrobial potential against Gram+ and Gram- bacteria. Two platforms have been compared 
for the bacterial growth: shaking flasks and 96-well titer plates. 
 
Nowadays available methods for antimicrobial studies are based on non-practical 
methodologies. These include plating bacterial suspensions that have been pre-incubated with 
antimicrobial solutions  [33,44], by disk diffusion tests [45] or cell viability tests with 
108 
 
fluorescent markers [33]. However these do not allow high-throughput screening (HTS) of 
antimicrobial peptides or minimum inhibitory concentration (MIC) determination.  
To overcome these drawbacks, HTS antimicrobial assays on multi-well format have been 
developed. The determination of bacterial viability relies on the measurement of a 
fluorescence signal [41,43] or the optical density  [32,44]. 
 
The comparison of two of the functionalized magnetic supports is summarized in Figure 6.3.  
 
 
Figure 6.3 - E. coli (EC) growth behavior in the presence of (RW)3-functionalized dextran-coated MNPs (a and b) and 
in the presence of (RW)3-functionalized PEG-coated MNPs (c and d). Two growth supports have been compared: 
shaking flasks (a and c) and 96-well titer plate (b and d). The antimicrobial agent was added at t=60min. 
 
If we compare the two methodologies (shaking flasks - Figure 6.3a and Figure 6.3c – and 96-
well titer plates - Figure 6.3b and Figure 6.3d) we can see that we have obtained similar growth 
behaviors for most cases. This shows that we can successfully use the 96-well titer plates to 
obtain the same results as with shaking flasks, which allows a more efficient screening, 
including HTS. 
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Two polymers have been used to coat the MNPs displayed in Figure 6.3. Dextran and PEG 
are non-toxic polymers that have previously been used for MNP coating [4,135]. As expected, 
polymer-coated MNPs do not have any antimicrobial effect in the bacteria growth (Figure 6.3, 
in green).  
The first support tested was dextran-coated MNPs functionalized with the Cys-(RW)3 
peptide via sulfo-coupling. No effect was observed on the growth of E. coli (Figure 6.3a and 
Figure 6.3b, in blue). The same behavior was observed for PEG-coated MNP functionalized by 
sulfo coupling (data not shown). A very high concentration has been tested (1mM), which 
should be enough to display antimicrobial activity [36]. As discussed in section 6.2, this was 
probably a consequence of the functionalization method and the peptide was not free to 
interact with the microbe membrane. The membrane disruption mechanism is dependent on 
the concentration of adsorbed peptide [136] and although we thought we were testing E. coli 
against an estimated concentration of 1mM we probably have a much lower peptide 
concentration at the MNP surface. On the other hand, the graft density of the peptide at the 
surface of the MNPs has an important role in its antimicrobial activity [41]. However this 
parameter is hard to control. Moreover it has been described that a lower grafting of the 
peptide onto the solid support may contribute for the partial adsorption of the bacteria to the 
particles and limit the peptide’s availability [33]. 
 
Other functionalization method was tested to conjugate (RW)3 to the PEG-coated MNPs 
with (RW)3. The peptide concentration tested was 0.5mM, the same concentration that 
showed to display antimicrobial activity against both strains (Figure 6.2). When we added the 
functionalized MNPs with 0.50mM of peptide at t=60min we can see that it disturbed the 
microbial growth, causing a decrease of the number of cells in solution. Moreover the same 
behavior is observed in both shaking flasks and 96-well titer plates - Figure 6.3c and Figure 
6.3d, respectively. Comparing the death rate (slope between t=60min (when the magnetic 
device was added) and the time when the microbial growth reaches its lowest value) we see 
they are in the same order of magnitude: 0.0030h-1 in the shaking flasks (t=60-90min) and 
0.0017h-1 in the 96-well titer plates (t=60-120min).  
In the shaking flasks, E. coli’s growth is inhibited for 1h30min, after which we can see an 
adaptation behavior and it slowly starts growing although with a 39% lower growth rate than 
E. coli alone (0.1247h-1 vs 0.3199h-1, respectively). This percentage is very similar to the 36% 
decrease in the growth rate reported by Hou et al while testing 0.20mM (RW)3 against E. coli 
[32]. On the other hand, a higher growth rate was reported for the (RW)3-incubated E. coli [32] 
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than in this study, which can be a first indication of a higher antimicrobial potential of the 
(RW)3-functionalized MNPs. 
On the other hand, when using the 96-well titer plates as support for the microbial growth 
a different profile was observed. E. coli only started to show some growth behavior 5h after 
incubation. This can be an indirect result of the lower solution homogenization due to the 96-
well titer plate wells’ geometry – each well is narrower than a shaking flask. 
 
The results in Figure 6.3c and Figure 6.3d were obtained for the incubation of the microbial 
culture with a final concentration of 0.50mM of peptide. An effective antimicrobial agent 
should have a high antimicrobial activity at a concentration that is non-toxic for mammalian 
cells [44]. (RW)3 has only displayed hemolytic activity against human red blood cells at 
0.745mM [134], which means that these devices would have low probability of showing 
toxicity against mammalian cells. 
 
Due to the MNP_PEG_NH2_(RW)3’s antimicrobial properties, these particles have been also 
tested against B. subtilis (Figure 6.4). 
 
 
Figure 6.4 - B. subtilis (BS) growth behavior in 96-well titer plate in the presence of (RW)3-functionalized MNPs in 
shaking flask. The antimicrobial agent was added at t=90min. 
Once again we observed a bactericidal effect of the (RW)3-functionalized MNPs. The growth 
behavior of B. subtilis is very similar to the results in Figure 6.3d for E.coli.  B. subtilis does not 
seem to be able to display a constant growth rate and lacks the adaptation capacity against the 
peptide. A longer experiment with E. coli may have shown the same behavior. 
The calculated death rate (t=90-150min) is higher than for E. coli in the same conditions 
(Figure 6.3d) - 0.0525h-1 vs 0.0017h-1, which would be expected due to the lack of outer layer 
of the Gram-positive bacteria. 
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Comparison with other AMP-functionalized nanodevices described in the literature (see 
Table 6.2) is a rather challenging task, as no author has used HTS analysis and most results are 
displayed as inhibition or cellular decrease percentages. On the other hand, the antimicrobial 
effects of (RW)3 have never been studied when tethered to a surface or other solid support. 
Zhang et al [38] functionalized magnetic iron oxide particles with bacitracin that displayed a 
higher antimicrobial activity than bacitracin itself. However this is not a typical behavior, as the 
solid support usually decreases the peptides’ antimicrobial activity [33,34]. 
Using MNP_PEG_NH2_(RW)3 we achieved close to 100% decrease of the microbial 
population for both strains. Blin et al [33] only achieved a 75% decrease of the microbial 
population while using magainin I-functionalized silica magnetic particles and conclude that 
better results could be achieved by tuning the concentration, size and treatment time. 
According to the literature, PEG seems to be a better choice as coating material. Moreover, 
Forbes and co-workers [44] have functionalized discs composed of various materials with 
antimicrobial apoE derivates and conclude that the two tested strains displayed the lowest 
percentage of survival when incubated with the PEG discs. 
 
 
6.4. Conclusions and Future Directions 
Two different methods to couple the peptide (RW)3 onto MNPs have been tested - via 
sulfo-coupling and EDC-coupling – and compared according to the immobilization efficiency 
and the antimicrobial potential of the final device. 
Although the sulfo-coupling methodology yielded higher immobilization percentages, the 
resulting particles did not display antimicrobial activity. It is probable that the terminal 
cysteine of the peptide used (Cys-(RW)3) was interacting with the magnetic core of the 
particles, which would result in lower amount of peptide available for interaction. This 
hypothesis was supported by the negative controls, which were performed in the absence of 
the sulfo-SMCC cross-linker: a large amount of peptide would interact non-specifically with the 
particles. On the other hand, the AMPs used in this work present a very positive zeta potential, 
which is a requisite to occur the interaction between the cationic peptide and the negatively 
charged bacteria membrane. The low amount of peptide at the MNP surface contributed for a 
lower zeta potential value, which may not be positive enough to interact membrane. 
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Better coating options should be explored to be able to use the sulfo-coupling strategy. The 
coating of iron oxide particles with a silica layer previously to the polymer layer showed 
promising results and decreased non-specific interaction of the peptide with the particles. 
 
To overcome the described disadvantages a different functionalization strategy was used: 
via EDC-coupling. Although lower immobilization percentages were achieved, the EDC-coupling 
methodology has resulted into a potential novel antimicrobial nanodevice with antimicrobial 
activity against E.coli and B. subtilis. A negative control was always performed to confirm that 
the antimicrobial activity was a result of the peptide and not of the non-functionalized 
particles. Furthermore, two growing platforms have been tested (shaking flasks vs 96-well titer 
plates). Comparable results were achieved in terms of death rate when MNP_PEG_NH2_(RW)3 
was tested against E. coli (0.0030h-1 and 0.0017h-1, respectively). On the other hand, a higher 
death rate was recorded for B. subtilis, which would be expected due to the lack of outer layer 
of the Gram-positive bacteria.  
However the work described above is only a first step and there are still many hypotheses 
to be explored. EDC-coupling is not the most efficient functionalization method for the (RW)3 
peptide, due to the large amount of amines of the peptide itself. The amount of peptide that 
we can tether to the MNPs is variable and the method should be optimized. Other 
functionalization techniques can be explored, as physical (adsorption, layer-by-layer assembly) 
or chemical (covalent bonding) methods. Onaizi and Leong have written a good review on this 
topic [137]. 
 
Comparison with other AMP-functionalized nanodevices described in the literature is 
complicated due to the different methodologies that have been used to analyze the 
antimicrobial potential. However, preliminary results are quite promising for a novel 
antimicrobial nanodevice. 
 
Due to their magnetic properties it should be interesting to re-use the particles above and 
analyze their antimicrobial potential after multiple rounds.  
In this work we were not able to test the double coating particles for their antimicrobial 
activity. However they have shown promising results when functionalized by the sulfo-coupling 
methodology, as well as a higher zeta potential (+27mV) than the devices described above.  
When testing novel antimicrobial molecules or devices two parameters are typically 
measured –  the MIC and the concentration where 50% of the red blood cells are lysed when 
exposed to the antimicrobial molecule [37]. To determine the MIC the same protocol can be 
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used, as the HTS method described above would allow the screening of a high number of 
concentrations simultaneously. 
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This work explored many different areas and techniques to achieve the proposed goals. 
 
In the first chapter several modeling techniques have been used successfully to explain the 
molecular interaction between two affinity pairs. The methodology involved building a 
homology model based on the target protein sequence, relaxing the model to avoid structural 
crashes through a first MD, finding the most promising docking poses and finally using a more 
extended MD simulation to analyze relevant interactions between the protein surface and the 
affinity ligand. 
The interaction between GFP/LA-A4C7 is mainly hydrophobic during a very significant 
percentage of the simulation time (over 90%). On the other hand, the interaction between RK-
GFP/LR-A7C1 is due to hydrogen bonding between tag residues and oxygen atoms of the 
ligand. However fewer docking results supported this hypothesis. 
Several methodological limitations do not allow us to conclude definitely about these 
interactions, as inefficient sampling, system simplification and accuracy of the force field. On 
the other hand, the criteria used to choose the docking poses may not be the most accurate. 
Therefore, this study can only be used as a first approach to explain the experimental results in 
[47]. 
Furthermore, a theoretical second generation for an Ugi affinity ligand for the purification 
of GFP has been developed with some potential better affinity ligands.  
 
In the second chapter we amplified and isolated pDNA containing the gene that expressed 
the protein of interest and used E. coli BL21 to produce crude extracts containing GFP or RK-
GFP. Afterwards, the affinity pairs described in [47] and studied in the 1st chapter were 
tethered onto MNPs and their affinity potential was accessed. 
We were able to bind and elute GFP using MNP_DEX_NH2_LA-A4C7, while testing different 
experimental conditions. The best conditions for GFP binding include higher MNP 
concentration with higher amination content and lower loading concentrations. However the 
solid support presented unspecific binding towards GFP. The best elution condition for GFP 
contains ethylene glycol, which contributes for the disruption of the hydrophobic interaction 
between GFP and LA-A4C7. However we could only obtain a yield of 44% and a final purity of 
86% in the elution fraction. 
On the other hand, the best elution condition for RK-GFP is based on a competition system 
with arginines. The LR-A7C1 functionalized-MNPs showed low specificity towards RK-GFP, as 
well as lower purity and yield of RK-GFP eluted than for the GFP/LR-A4C7 system 
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For GFP/LA-A4C7 and RK-GFP/LR-A7C1 affinity systems we achieved quite promising Ka 
values for an affinity-based protein purification system. However several experimental 
conditions have to be previously optimized for this new solid support. 
 
In the third chapter, two different peptide coupling methods onto MNPs have been tested - 
via sulfo-coupling and EDC-coupling  
Although the sulfo-coupling methodology yielded higher immobilization percentages, the 
resulting particles did not display antimicrobial activity due to the interaction between the 
terminal cysteine of Cys-(RW)3 and the magnetic core and low positive zeta potential. Better 
coating options (e.g. silica/PEG) should be explored to be able to use this immobilization 
strategy. 
To overcome the described disadvantages a different functionalization strategy was used: 
via EDC-coupling, which resulted in a novel antimicrobial nanodevice with antimicrobial 
activity against Gram-negative and Gram-positive bacteria. A higher death rate was recorded 
for B. subtilis than for E. coli, which would be expected due to the lack of outer layer of the 
Gram-positive bacteria. However the EDC-coupling methodology is not the most efficient 
functionalization method for the amine-rich (RW)3 peptide 
We also proved the reproducibility of the results when using classical growing supports 
(shaking flasks) and a HTS method (96-well titer plates), with comparable results. The HTS 
method allows a more efficient and rapid screening method.  
There are still many hypotheses to be explored, including a more efficient functionalization 
method, reusability of the particles, MIC determination of the novel nanodevice and different 
coating options. 
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